Processing 00000000.tx.1: The Neuropeptide Processing Enzyme EC 3.4.24.15 Is Modulated by Protein Kinase A Phosphorylation* John W. 

Phrase: "The Neuropeptide Processing Enzyme EC 3.4.24.15"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0014442:Enzyme [Enzyme,Organic Chemical]
   793   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   793   C1709694:Processing [Activity]
   760 E C1184743:Process [Body Part, Organ, or Organ Component]
   760 E C1522240:Process [Phenomenon or Process]
   710 E C0014445:enzymes [Functional Concept]

Phrase: "Is"

Phrase: "Modulated by Protein Kinase A Phosphorylation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0443264:Modulated [Spatial Concept]

Phrase: "* John W."
Processing 00000000.tx.2: Tullai, Philip M. 

Phrase: "Tullai,"

Phrase: "Philip M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Cummins, Amanda Pabon, James L. 

Phrase: "Cummins,"

Phrase: "Amanda Pabon,"

Phrase: "James L."
Processing 00000000.tx.4: Roberts, Maria C. 

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "Maria C."
Processing 00000000.tx.5: Lopingco, Corie N. 

Phrase: "Lopingco,"

Phrase: "Corie N."
Processing 00000000.tx.6: Shrimpton, A. 

Phrase: "Shrimpton,"

Phrase: "A."
Processing 00000000.tx.7: Ian Smith, John A. 

Phrase: "Ian Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "John A."
Processing 00000000.tx.8: Martignetti, Emer S. 

Phrase: "Martignetti,"

Phrase: "Emer S."
Processing 00000000.tx.9: Ferro, and Marc J. 

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "and"

Phrase: "Marc J."
Processing 00000000.tx.10: Glucksman** From the Fishberg Research Center for Neurobiology and Departments of Human Genetics and Pediatrics, Mount Sinai School of Medicine, New York, New York 10029and the Peptide Biology Laboratory, Baker Medical Research Institute, P.O.Box 6492,Melbourne, Victoria 8008,Australia Received for publication, March 6,2000, and in revised form, August 29,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The metalloendopeptidase EC 3.4.24.15 (EP24.15) is a neuropeptide-metabolizing enzyme expressed predominantly in brain, pituitary, and testis, and is implicated in several physiological processes and diseases. 

Phrase: "Glucksman"

Phrase: "*"

Phrase: "*"

Phrase: "From the Fishberg Research Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "for Neurobiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027817:Neurobiology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Departments of Human Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0587466:Genetics department [Health Care Related Organization]
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pediatrics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030755:Paediatrics [Biomedical Occupation or Discipline]

Phrase: "Mount Sinai School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10029and"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "the Peptide Biology Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C3244292:laboratory [Functional Concept]

Phrase: "Baker Medical Research Institute,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0035172:Research Institute [Organization]
   861   C0079816:Medical Research [Research Activity]
   861   C1556038:Medical Research [Professional or Occupational Group]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0205476:Medical [Functional Concept]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "P.O.Box 6492,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0179400:Box [Manufactured Object]
   812   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1533124:Box [Medical Device]
   812   C2603361:P' [Clinical Attribute]

Phrase: "Melbourne,"

Phrase: "Victoria 8008,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042645:Victoria [Geographic Area]
   861   C0997115:Victoria [Plant]

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "March 6,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "August 29,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The metalloendopeptidase EC 3.4.24.15 (EP24.15)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   904   C0207304:metalloendopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a neuropeptide-metabolizing enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "expressed"

Phrase: "predominantly in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "pituitary,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "testis,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "is"

Phrase: "implicated in several physiological processes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0031845:Physiological Processes [Physiologic Function]
   760   C0205463:Physiological [Functional Concept]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "diseases."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.11: Multiple putative phosphorylation sites in the primary sequence led us to investigate whether phosphorylation effects the specificity and/or the kinetics of substrate cleavage. 

Phrase: "Multiple putative phosphorylation sites in the primary sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   767   C0449695:primary sites [Spatial Concept]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0205145:Sites [Spatial Concept]
   744   C1158886:Phosphorylation [Molecular Function]
   737   C1519063:Phosphorylation Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "phosphorylation effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "the specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "and/or"

Phrase: "the kinetics of substrate cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022702:Kinetics [Natural Phenomenon or Process]
   760   C0220865:kinetics [Functional Concept]
   760   C2825046:Kinetics [Occupation or Discipline]
Processing 00000000.tx.12: Only protein kinase A (PKA) treatment resulted in serine phosphorylation with a stoichiometry of 1.110.12mol of phosphate/mol of recombinant rat EP24.15. 

Phrase: "Only protein kinase A (PKA) treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]
   717   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resulted in serine phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1158886:Phosphorylation [Molecular Function]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "with a stoichiometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "of 1.110.12mol"

Phrase: "of phosphate/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]

Phrase: "of recombinant rat EP24.15."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C1514798:recombinant [Organism]
Processing 00000000.tx.13: Mutation analysis of each putative PKA site, in vitro phosphorylation, and phosphopeptide mapping indicated serine 644as the phosphorylation site. 

Phrase: "Mutation analysis of each putative PKA site,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0796357:mutation analysis [Laboratory Procedure]
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "in vitro phosphorylation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "phosphopeptide mapping indicated serine 644as"

Phrase: "the phosphorylation site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519063:Phosphorylation Site [Amino Acid Sequence]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C0205145:Site [Spatial Concept]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.14: Phosphorylation effects on catalytic activity were assessed using physiological (GnRH, GnRH1-9, bradykinin, and neurotensin) and fluorimetric (MCA-PLGPDL-Dnp and orthoaminobenzoyl-GGFLRRV-Dnp-edn) substrates. 

Phrase: "Phosphorylation effects on catalytic activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "(GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "GnRH1-9,"

Phrase: "bradykinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "and"

Phrase: "neurotensin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "fluorimetric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0016352:Fluorimetry [Laboratory Procedure]

Phrase: "(MCA-PLGPDL-Dnp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0045511:DNP [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0678100:DNP [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "orthoaminobenzoyl-GGFLRRV-Dnp-edn) substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.15: The most dramatic change upon PKA phosphorylation was a substrate-specific, 7-fold increase in both Km and kcat for GnRH. 

Phrase: "The most dramatic change upon PKA phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0025320:The change [Physiologic Function]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "a substrate-specific, 7-fold increase in both Km"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "kcat for GnRH."
Processing 00000000.tx.16: In both rat PC12 and mouse AtT-20 cells, EP24.15 was serine-phosphorylated, and EP24.15 phosphate incorporation was enhanced by forskolin treatment, and attenuated by H89, consistent with PKA-mediated phosphorylation. 

Phrase: "In both rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "mouse AtT-20 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "serine-phosphorylated,"

Phrase: "and"

Phrase: "EP24.15 phosphate incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "enhanced by forskolin treatment,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C2349975:Enhanced [Activity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "attenuated by H89,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0082782:h89 [Organic Chemical,Pharmacologic Substance]
   790   C0332161:Attenuated [Qualitative Concept]
   790   C0599946:Attenuated [Activity]

Phrase: "consistent with PKA-mediated phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.17: Cloning of the full-length mouse EP24.15 cDNA revealed 96.7% amino acid identity to the rat sequence, and conservation at serine 644,consistent with its putative functional role. 

Phrase: "Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "of the full-length mouse EP24.15 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "96.7% amino acid identity to the rat sequence,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0424215:Identity [Mental Process]
   742   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "conservation at serine 644,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347858:Conservation [Qualitative Concept]

Phrase: "consistent with its putative functional role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.18: Therefore, PKA phosphorylation is suggested to play a regulatory role in EP24.15 enzyme activity.  

Phrase: "Therefore,"

Phrase: "PKA phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   812   C0031715:Phosphorylation [Molecular Function]
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a regulatory role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "in EP24.15 enzyme activity."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   818   C0243102:enzyme activity [Molecular Function]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   712 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.19: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Intracellular communication is a vital regulator of the fundamental processes of metabolism, growth, and differentiation in all organisms. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Intracellular communication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1371606:Intracellular Communication [Cell Function]
   861   C0009452:Communication [Social Behavior]

Phrase: "is"

Phrase: "a vital regulator of the fundamental processes of metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0182953:REGULATOR [Medical Device]
   742   C1704734:Regulator [Medical Device]
   742   C1704735:Regulator [Conceptual Entity]

Phrase: "growth,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "differentiation in all organisms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.20: Neuropeptides are involved in autocrine, paracrine, and endocrine signaling allowing cells to communicate without necessarily requiring close synaptic proximity (1). 

Phrase: "Neuropeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "are"

Phrase: "involved in autocrine, paracrine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0596138:Autocrine [Organ or Tissue Function]
   770   C0597170:paracrine [Physiologic Function]
   770   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "endocrine signaling allowing cells to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0229525:Endocrine Cells [Cell]
   781   C0037083:Cell Signaling [Cell Function]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "communicate without necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0566001:communicate [Finding]

Phrase: "requiring"

Phrase: "close synaptic proximity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514583:Proximity [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: Neuropeptides are unique from other neurotransmitters in that peptides lack classical reuptake mechanisms for recycling components into the cell and terminating action. 

Phrase: "Neuropeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "are"

Phrase: "unique from other neurotransmitters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710548:Unique [Qualitative Concept]

Phrase: "in that peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "classical reuptake mechanisms for recycling components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "into the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "terminating action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]
Processing 00000000.tx.22: Instead, neuropeptide-metabolizing enzymes are required to extinguish the signaling action of neuropeptides. 

Phrase: "Instead,"

Phrase: "neuropeptide-metabolizing enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extinguish"

Phrase: "the signaling action of neuropeptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]
Processing 00000000.tx.23: The zinc metalloendopeptidase EC 3.4.24.15 (EP24.15)1 exhibits characteristics of both metabolizing and processing enzymes, and has multiple peptide substrates. 

Phrase: "The zinc metalloendopeptidase EC 3.4.24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0207304:metalloendopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   795   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "(EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "characteristics of both metabolizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "processing enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "has"

Phrase: "multiple peptide substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.24: One substrate, GnRH, is of critical physiological importance in reproduction. 

Phrase: "One substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "is of critical physiological importance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205463:Physiological [Functional Concept]
   760   C1511545:Critical [Qualitative Concept]

Phrase: "in reproduction."
Meta Candidates (Total=16; Excluded=15; Pruned=0; Remaining=1)
  1000   C0035150:Reproduction [Organism Function]
   944 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   944 E C0314603:Genetic [Functional Concept]
   944 E C0559522:Genital [Body System]
   944 E C1546649:Genital [Intellectual Product]
   944 E C1550642:Genital [Body Substance]
   916 E C0005615:Birth [Organism Function]
   916 E C0079946:origin [Classification]
   916 E C0439659:Origin [Temporal Concept]
   916 E C1550512:origin [Intellectual Product]
   916 E C1550722:birth [Idea or Concept]
   916 E C3245487:birth [Intellectual Product]
   900 E C0454729:Natal [Geographic Area]
   893 E C0205313:Original [Idea or Concept]
   893 E C2347409:Original [Occupational Activity]
   880 E C0598240:originality [Mental Process]
Processing 00000000.tx.25: Inhibition of EP24.15 activity has been demonstrated in vivo in rat models resulting in an increased half-life of the hormone by decreased GnRH degradation and subsequent augmentation of the luteinizing hormone surge (2-4). 

Phrase: "Inhibition of EP24.15 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "in vivo in rat models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1515657:In Vivo Model [Research Activity]
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "resulting in an increased half-life of the hormone"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C0018517:Half-Life [Temporal Concept]
   764   C0332294:Resulting in [Functional Concept]
   742   C0019932:Hormone [Hormone]
   742   C0205217:Increased [Quantitative Concept]
   742   C0376558:Life [Idea or Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0678226:resulting [Functional Concept]
   742   C2825407:Half [Quantitative Concept]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "by decreased GnRH degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "subsequent augmentation of the luteinizing hormone surge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "(2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.26: Other important EP24.15 substrate targets include neurotensin, where inhibition of EP24.15 in mice prolonged forepaw licking latency (5), bradykinin (6), somatostatin1-14 (7), and nociceptin (8). 

Phrase: "Other important EP24.15 substrate targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "neurotensin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: "where inhibition of EP24.15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "prolonged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439590:Prolonged [Temporal Concept]

Phrase: "forepaw"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1533572:Forepaw [Body Part, Organ, or Organ Component]
  1000   C1630649:Forepaw [Body Part, Organ, or Organ Component]

Phrase: "licking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233928:Licking [Individual Behavior]

Phrase: "latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205275:Latent [Qualitative Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "somatostatin1-14"

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "nociceptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0382336:nociceptin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.27: EP24.15 also processes Met- and Leu-enkephalin from the enkephalin-containing peptides (9), and the specific EP24.15 inhibition increased Met-enkephalin antinociception in rodents (10). 

Phrase: "EP24.15 also processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1184743:Process [Body Part, Organ, or Organ Component]
   762   C1522240:Process [Phenomenon or Process]

Phrase: "Met-"

Phrase: "and"

Phrase: "Leu-enkephalin from the enkephalin-containing peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0014294:Leu-Enkephalin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1418447:leu-enkephalin [Gene or Genome]
   748   C0014298:Enkephalin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the specific EP24.15 inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   795   C0021467:Inhibition [Mental Process]
   795   C0021469:Inhibition [Molecular Function]
   795   C1628982:% inhibition [Quantitative Concept]
   795   C3463820:Inhibition [Activity]
   724 E C0311403:Inhibited [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "Met-enkephalin antinociception in rodents"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.28: The enzyme has also been implicated in regulation of the cleavage of amyloid- peptide (11), the aberrant processing of which has been linked to Alzheimer's disease pathogenesis. 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "implicated in regulation of the cleavage of amyloid- peptide"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0010813:cleavage [Cell Function]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]
   742   C1330957:cleavage [Cell Function]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "the aberrant processing of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "linked to Alzheimer's disease pathogenesis."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.29: The regulation of EP24.15 action upon its substrates is achieved by unique elements such as thiol activation (12). 

Phrase: "The regulation of EP24.15 action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "upon its substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "is"

Phrase: "achieved by unique elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0013879:Elements [Element, Ion, or Isotope]
   770   C1710548:Unique [Qualitative Concept]
   737 E C1705248:Element [Conceptual Entity]

Phrase: "such as thiol activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.30: Another regulatory mechanism may be phosphorylation, which represents an important means of neural extracellular signal transduction and biological response modulation (13). 

Phrase: "Another regulatory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "which"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an important means of neural extracellular signal transduction"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C1704970:Means [Conceptual Entity]
   711 E C0444504:Mean [Quantitative Concept]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "biological response modulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0678672:biological modulation [Cell Function]
   827   C0443264:Modulation [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: Indeed, modulation of protease activity by phosphorylation has been demonstrated in proteasomes (14) and more recently, in the caspase family of proteases (15, 16). 

Phrase: "Indeed,"

Phrase: "modulation of protease activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]

Phrase: "by phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated in proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C1325620:proteasome [Cell Component]
   756 E C1752727:Proteasome [Molecular Function]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "more recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "in the caspase family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "of proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.32: Of particular interest, treatment of rat pheochromocytoma cells (PC12) by a cAMP analogue decreased the specific activity of soluble EP24.15 (17). 

Phrase: "Of particular interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:Interest [Mental Process]

Phrase: "treatment of rat pheochromocytoma cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "(PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "by a cAMP analogue"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   755 E C0679213:analogies [Idea or Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the specific activity of soluble EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0205177:Activity [Functional Concept]
   739   C0205369:Specific [Qualitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1552740:specific [Intellectual Product]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.33: This would suggest modulation of EP24.15 protein by PKA phosphorylation, or by another kinase activated through PKA (18, 19). 

Phrase: "This"

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "modulation of EP24.15 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]

Phrase: "by PKA phosphorylation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   812   C0031715:Phosphorylation [Molecular Function]
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "or by another kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "activated through PKA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.34: Indeed, the amino acid sequence of EP24.15 contains PKA, CKII, and PKC consensus phosphorylation motifs (20), suggesting that the enzyme may be a kinase substrate in mammalian cells. 

Phrase: "Indeed,"

Phrase: "the amino acid sequence of EP24.15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0202406:Acid [Laboratory Procedure]
   739   C1519249:Sequence [Functional Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "PKA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "CKII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707154:CKII [Gene or Genome]

Phrase: "and"

Phrase: "PKC consensus phosphorylation motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514562:Motif [Amino Acid Sequence]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a kinase substrate in mammalian cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.35: To build on the indirect observation of possible kinase influences on EP24.15 activity in rat PC12 cells (17), we sought to determine the role of phosphorylation upon EP24.15, specifically examining its effect on neuropeptide hydrolysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "build on the indirect observation of possible kinase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0302523:Observation [Research Activity]
   744   C0332149:Possible [Qualitative Concept]
   744   C0439852:Indirect [Qualitative Concept]
   744   C0700325:observation [Health Care Activity]
   744   C1705910:Possible [Qualitative Concept]
   744   C1707059:Build [Conceptual Entity]
   744   C1964257:Observation [Diagnostic Procedure]
   744   C2362652:Possible [Qualitative Concept]

Phrase: "influences on EP24.15 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "in rat PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the role of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "upon EP24.15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "specifically"

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "its effect on neuropeptide hydrolysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.36: Similarly, it would be important to determine if phosphorylation is a conserved event in other neuroendocrine/peptide hydrolysis model systems, such as in AtT-20 mouse pituitary cells.  

Phrase: "Similarly,"

Phrase: "it"

Phrase: "would"

Phrase: "be"

Phrase: "important to"

Phrase: "determine"

Phrase: "if"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "a conserved event in other neuroendocrine/peptide hydrolysis model systems,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0441471:Event [Event]

Phrase: "such as"

Phrase: "in AtT-20 mouse pituitary cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   823   C0229535:Pituitary cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.37: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Materials-- Reagents were purchased from Sigma unless otherwise noted. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.38: Protein Expression and Mutagenesis Rat EP24.15 (accession number P24155) was expressed and purified, and site-directed mutagenesis performed using the EP24.15 expression vector, GEX-24.15 (21), as described previously (12, 22). 

Phrase: "Protein Expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Mutagenesis Rat EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C0079866:Mutagenesis [Molecular Function]
   795   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "(accession number P24155"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "expressed"

Phrase: "and"

Phrase: "purified,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "site-directed mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the EP24.15 expression vector,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0442335:Vector [Spatial Concept]
   795   C1705099:Vector [Idea or Concept]

Phrase: "GEX-24.15"

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.39: Prokaryotic codon usage rules were used to prevent the use of rare codons that may hinder expression of the mutant proteins as follows: S98A (ACATCCGCGCAGCCGCCACAGAGGCTGACAAG), S106A (CTGACAAGAAGCTCGCAGAGTTTGATGTGG), S172A (TCAAGAAGAGGCTGGCCCTGCTGTGCATC), S288A (GAACATGGCCAAGACCGCTCAGACAGTAGCCACC), S398A (GACGTGCGGCTGTACGCCGTGCGTGACGCCG), S522A (GCCACTGATGCGCATGGCCCAGCATTACCG), and S644A (CATGGATTACCGGACCGCCATCCTGAGGCCG). 

Phrase: "Prokaryotic codon usage rules"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0870077:Rules [Intellectual Product]
   779 E C0805874:Rule [Idea or Concept]
   779 E C1446409:rule [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the use of rare codons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "hinder"

Phrase: "expression of the mutant proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "S98A"

Phrase: "(ACATCCGCGCAGCCGCCACAGAGGCTGACAAG"

Phrase: ")"

Phrase: ","

Phrase: "S106A"

Phrase: "(CTGACAAGAAGCTCGCAGAGTTTGATGTGG"

Phrase: ")"

Phrase: ","

Phrase: "S172A"

Phrase: "(TCAAGAAGAGGCTGGCCCTGCTGTGCATC"

Phrase: ")"

Phrase: ","

Phrase: "S288A"

Phrase: "(GAACATGGCCAAGACCGCTCAGACAGTAGCCACC"

Phrase: ")"

Phrase: ","

Phrase: "S398A"

Phrase: "(GACGTGCGGCTGTACGCCGTGCGTGACGCCG"

Phrase: ")"

Phrase: ","

Phrase: "S522A"

Phrase: "(GCCACTGATGCGCATGGCCCAGCATTACCG"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "S644A"

Phrase: "(CATGGATTACCGGACCGCCATCCTGAGGCCG"

Phrase: ")."
Processing 00000000.tx.40: At least two independent preparations of wild type protein and each mutant were purified and characterized, with similar homogeneity, yields, and kinetic parameters. 

Phrase: "At least two independent preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "of wild type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "each mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "characterized,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "with similar homogeneity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881065:Homogeneity [Qualitative Concept]

Phrase: "yields,"

Phrase: "and"

Phrase: "kinetic parameters."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]
Processing 00000000.tx.41: Proteins were snap frozen and stored at 80C for subsequent analyses. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "snap"

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "and"

Phrase: "stored at 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "for subsequent analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.42: SDS- and Native-PAGE Samples for SDS-PAGE were heated in 2sample buffer at 65C for 5min. 

Phrase: "SDS-"

Phrase: "and"

Phrase: "Native-PAGE Samples for SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "heated in 2sample buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   737   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "at 65C"

Phrase: "for 5min."
Processing 00000000.tx.43: The proteins were separated on an 8% SDS-polyacrylamide gel as described by Laemmli (23). 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated on an 8% SDS-polyacrylamide gel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1382104:Gel [Substance]

Phrase: "as"

Phrase: "described by Laemmli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.44: Native gels were run similarly except SDS and -mercaptoethanol were omitted from both the sample buffer and the polyacrylamide gel, and samples were not heated. 

Phrase: "Native gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "similarly except SDS"

Phrase: "and -"

Phrase: "mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "were"

Phrase: "omitted from both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750563:omitted [Idea or Concept]

Phrase: "the sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "the polyacrylamide gel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "heated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018837:Heat [Natural Phenomenon or Process]
Processing 00000000.tx.45: After electrophoresis, the gels containing radiolabeled EP24.15 were exposed to film or to a phosphor screen (Molecular Dynamics, Sunnyvale, CA) for quantitation. 

Phrase: "After electrophoresis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "the gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "radiolabeled EP24.15"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1527121:Radiolabeled [Qualitative Concept]
   766 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]

Phrase: "or to a phosphor screen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0220908:screen [Health Care Activity]
   760   C0259980:phosphor [Chemical Viewed Functionally]
   760   C1305399:screen [Functional Concept]
   760   C1705053:Screen [Medical Device]

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Sunnyvale,"

Phrase: "CA) for quantitation."
Processing 00000000.tx.46: Phosphorylation Assays For PKA-- 5-30 units of PKA/g of EP24.15 (1unit=amount of enzyme required to transfer 1nmol of phosphate to Kemptide substrate LRRASLG in 1min at 30C; PKA catalytic subunit, New England Biolabs, Beverly, MA) were incubated in PKA reaction buffer (50mM Tris, 10mM MgCl2, 0.3mM dithiothreitol, pH 7.5). 

Phrase: "Phosphorylation Assays For PKA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "5-30 units of PKA/g"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C1706058:Protein Unit [Quantitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1unit"

Phrase: "=amount of enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1265611:Amount [Quantitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "1nmol of phosphate"

Phrase: "to Kemptide substrate LRRASLG"

Phrase: "in 1min"

Phrase: "at 30C"

Phrase: "; PKA catalytic subunit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0599220:Protein Subunit [Amino Acid, Peptide, or Protein]
   840   C0600499:Catalytic Subunit [Amino Acid Sequence]
   804   C1711351:Subunit [Quantitative Concept]
   717   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "New England Biolabs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: "Beverly,"

Phrase: "MA)"

Phrase: "were"

Phrase: "incubated in PKA reaction buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "(50mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.3mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.47: Kemptide (LRRASLG) served as positive control. 

Phrase: "Kemptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064282:kemptide [Amino Acid, Peptide, or Protein]

Phrase: "(LRRASLG"

Phrase: ")"

Phrase: "served as positive control."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1883676:Positive Control [Conceptual Entity]
   770   C0243148:control [Qualitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.48: For CKII-- 50-300 units of CKII/g of EP24.15 (1unit=amount of enzyme required to transfer 1pmol of phosphate to RRREEETEEE peptide in 1min at 30C; New England BioLabs) were incubated in CKII reaction buffer (20mM Tris-HCl, 50mM KCl, 10mM MgCl2, 0.3mM dithiothreitol, pH 7.5). 

Phrase: "For CKII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707154:CKII [Gene or Genome]

Phrase: "--"

Phrase: "50-300 units of CKII/g"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439148:Units [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1unit"

Phrase: "=amount of enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1265611:Amount [Quantitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "1pmol of phosphate"

Phrase: "to RRREEETEEE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "in 1min"

Phrase: "at 30C"

Phrase: "; New England BioLabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "incubated in CKII reaction buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1707154:CKII [Gene or Genome]

Phrase: "(20mM Tris-HCl,"

Phrase: "50mM KCl,"

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.3mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.49: The peptide RRREEETEEE served as positive control. 

Phrase: "The peptide RRREEETEEE"

Phrase: "served as positive control."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1883676:Positive Control [Conceptual Entity]
   770   C0243148:control [Qualitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.50: For PKC-- PKC was purified from Rat 6fibroblast cell lines overexpressing PKC (calcium independent) or PKC (calcium dependent) (gift of Dr. Robert Krauss, Mount Sinai School of Medicine) and assays were performed as described elsewhere (24, 25), using 3g of EP24.15; 

Phrase: "For PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "--"

Phrase: "PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "was"

Phrase: "purified from Rat 6fibroblast cell lines"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   804   C1514733:Rat Cell Line [Cell]
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C1998793:Purified [Functional Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "(calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "independent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085862:Independent [Idea or Concept]
  1000   C1299583:Independent [Finding]

Phrase: ")"

Phrase: "or"

Phrase: "PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "(calcium dependent"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C2936886:Calcium [Pharmacologic Substance]
   861   C3244310:dependent [Functional Concept]

Phrase: ")"

Phrase: "(gift of Dr. Robert Krauss,"

Phrase: "Mount Sinai School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: ")"

Phrase: "and"

Phrase: "assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(24,"

Phrase: "25"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "3g of EP24.15"

Phrase: ";"
Processing 00000000.tx.51: each condition was assayed in triplicate. 

Phrase: "each condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was"

Phrase: "assayed in triplicate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205174:Triplicate [Quantitative Concept]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.52: EGF receptor peptide (RKRTLRRL) served as positive control. 

Phrase: "EGF receptor peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   734   C0034802:Receptor, EGF [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "(RKRTLRRL"

Phrase: ")"

Phrase: "served as positive control."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1883676:Positive Control [Conceptual Entity]
   770   C0243148:control [Qualitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.53: Each kinase was incubated with or without 200M ATP (800M ATP for PKC assays) (Roche Molecular Biochemicals, Indianapolis, IN), with the addition of trace amounts (0.04mCi, 3000Ci/mmol) of [-32P]ATP (New England Nuclear, Boston, MA). 

Phrase: "Each kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "or without 200M ATP"

Phrase: "(800M ATP for PKC assays"

Phrase: ")"

Phrase: "(Roche Molecular Biochemicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: "Indianapolis,"

Phrase: "IN"

Phrase: ")"

Phrase: ","

Phrase: "with the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of trace amounts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0442822:trace amount [Quantitative Concept]
   861   C1265611:amounts [Quantitative Concept]

Phrase: "(0.04mCi,"

Phrase: "3000Ci/mmol) of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "(New England Nuclear, Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.54: Under the assay conditions, there was no incorporation in the absence of kinase. 

Phrase: "Under the assay conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "there"

Phrase: "was"

Phrase: "no incorporation in the absence of kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.55: Reactions for time course experiments were terminated by the addition of equal volumes of 0.5mM EDTA (to prevent chemical, non-enzymatic phosphorylation from occurring upon heating) (26), sample loading buffer containing -mercaptoethanol, and heating to 65C for 10min. 

Phrase: "Reactions for time course experiments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0034746:Reaction Time [Temporal Concept]
   726   C0443286:Reaction [Functional Concept]
   726   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "terminated by the addition of equal volumes of 0.5mM EDTA (to"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   751   C0205163:Equal To [Qualitative Concept]
           Equal
   736   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   736   C0449468:volumes [Quantitative Concept]
   736   C1549782:Equal [Idea or Concept]
   736   C1553404:terminated [Idea or Concept]
   736   C1883712:Addition [Functional Concept]
   736   C2348570:Terminated [Functional Concept]
   703 E C1690016:% volume [Qualitative Concept]
   703 E C1705102:Volume [Intellectual Product]
   703 E C2700258:Volume [Laboratory Procedure]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "chemical, non-enzymatic phosphorylation from"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "occurring upon heating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018851:Heating [Environmental Effect of Humans]
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: ")"

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "sample loading buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "heating to 65C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018851:Heating [Environmental Effect of Humans]

Phrase: "for 10min."
Processing 00000000.tx.56: Samples were then electrophoresed on an 8% SDS-PAGE gel, dried, and exposed to film or to a phosphorscreen for PhosphorImager analyses. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "electrophoresed on an 8% SDS-PAGE gel,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1382104:Gel [Substance]
   748   C1704732:Page [Intellectual Product]
   714   C0013855:electrophorese [Laboratory Procedure]

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]

Phrase: "or to a phosphorscreen"

Phrase: "for PhosphorImager analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.57: Quantitation of Incorporated Phosphate Prior to inactivation of the kinase assays (described above), a 2-l aliquot was spotted onto P81 cellulose phosphate paper (Life Technologies, Grand Island, NY) (representing total counts). 

Phrase: "Quantitation of Incorporated Phosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "Prior to inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of the kinase assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(described above"

Phrase: ")"

Phrase: ","

Phrase: "a 2-l aliquot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "spotted onto P81 cellulose phosphate paper"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0070824:cellulose phosphate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   753   C0030351:Paper [Manufactured Object]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0059973:p81 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1547566:Paper [Idea or Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719   C0329155:Spot [Fish]
   719   C1427618:SPOT [Gene or Genome]
   719   C1705203:Spot [Conceptual Entity]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "("

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "total counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.58: The sample was allowed to dry, washed with 75mM phosphoric acid (specific incorporation) (425ml, where no more label was eluted), counted, and moles of phosphate incorporated per mole of EP24.15S.E. calculated. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011682:Dry [Natural Phenomenon or Process]
  1000   C0205222:Dry [Qualitative Concept]
  1000   C1512080:Dry [Qualitative Concept]

Phrase: ","

Phrase: "washed with 75mM phosphoric acid"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0031700:Phosphoric acid [Inorganic Chemical,Pharmacologic Substance]
   806   C0031702:phosphoric acid [Inorganic Chemical]
   806   C1161325:phosphoric acid [Inorganic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0031705:Phosphoric [Element, Ion, or Isotope]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1548982:Washed [Idea or Concept]
   726 E C0441648:Wash [Activity]

Phrase: "(specific incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: ")"

Phrase: "(425ml,"

Phrase: "where"

Phrase: "no more label"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181496:Label [Manufactured Object]
   861   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "eluted"

Phrase: ")"

Phrase: ","

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "moles of phosphate"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0027960:Moles [Neoplastic Process]
   790   C0027962:moles [Neoplastic Process]
   790   C0324740:Moles [Mammal]
   790   C1456781:moles [Neoplastic Process]
   756 E C0439189:Mole [Quantitative Concept]
   706 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: "incorporated per mole of EP24.15S.E."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0027960:Mole [Neoplastic Process]
   748   C0324740:Mole [Mammal]
   748   C0439189:Mole [Quantitative Concept]
   748   C1456781:mole [Neoplastic Process]
   748   C1552129:15s [Body Part, Organ, or Organ Component]
   748   C1824986:mol [Gene or Genome]

Phrase: "calculated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.59: To ensure phosphorylation saturation, controls included: decreasing substrate concentration, increasing kinase concentrations, increasing ATP concentration, and examining time course reactions by PhosphorImager analyses for time-dependent saturation of signal. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "phosphorylation saturation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0522534:Saturation [Phenomenon or Process]
   789 E C1705188:SATURATED [Quantitative Concept]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ":"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "substrate concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "kinase concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "ATP concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "examining time course reactions by PhosphorImager analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0034746:Reaction Time [Temporal Concept]
   714   C0443286:Reaction [Functional Concept]
   714   C1114821:Reaction [Clinical Attribute]

Phrase: "for time-dependent saturation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0522534:Saturation [Phenomenon or Process]
   755 E C1705188:SATURATED [Quantitative Concept]

Phrase: "of signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.60: There was no incorporation in the absence of kinase. 

Phrase: "There"

Phrase: "was"

Phrase: "no incorporation in the absence of kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.61: Additionally, after saturation of phosphate incorporation (90min, 10units of PKA), an additional 10units of PKA was added, demonstrating that saturation was not due to kinase depletion. 

Phrase: "Additionally,"

Phrase: "after"

Phrase: "saturation of phosphate incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522534:Saturation [Phenomenon or Process]

Phrase: "(90min,"

Phrase: "10units of PKA"

Phrase: ")"

Phrase: ","

Phrase: "an additional 10units of PKA"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "demonstrating"

Phrase: "that saturation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522534:Saturation [Phenomenon or Process]
   928 E C1705188:SATURATED [Quantitative Concept]

Phrase: "was"

Phrase: "not due to kinase depletion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0333668:Depletion [Functional Concept]
   760   C1518422:Not [Functional Concept]
   760   C3146286:Due [Idea or Concept]
Processing 00000000.tx.62: Kinetic Determinations Using the Fluorimetric Substrates QFS and QF7 EP24.15 enzymatic activity was determined under discontinuous assay conditions with the quenched fluorescent substrate QFS (27) and QF7 (28), as described previously with modifications. 

Phrase: "Kinetic Determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Fluorimetric Substrates QFS"

Phrase: "and"

Phrase: "QF7 EP24.15 enzymatic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C2267219:Enzymatic Activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined under discontinuous assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0439599:Discontinuous [Temporal Concept]
   770   C1444662:Discontinuous [Finding]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "conditions with the quenched fluorescent substrate QFS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0012634:condition [Disease or Syndrome]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0348080:Condition [Qualitative Concept]
   748   C1705253:Condition [Conceptual Entity]
   748   C1710236:Substrate [Manufactured Object]

Phrase: "(27"

Phrase: ")"

Phrase: "and"

Phrase: "QF7"

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously with modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0392747:Modification [Functional Concept]
   756   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.63: The non-phosphorylated EP24.15 enzyme (control) used for all kinetic determinations underwent identical kinase reaction conditions (described above), except that ATP was excluded. 

Phrase: "The non-phosphorylated EP24.15 enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0014442:Enzyme [Enzyme,Organic Chemical]
   710 E C0014445:enzymes [Functional Concept]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "used for all kinetic determinations"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   760   C0022702:kinetic [Natural Phenomenon or Process]
   760   C0680730:determinations [Governmental or Regulatory Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1148554:determination [Laboratory Procedure]
   726 E C1947944:Use [Intellectual Product]
   704 E C0026597:Motion [Natural Phenomenon or Process]
   704 E C0687704:Motions [Functional Concept]

Phrase: "underwent"

Phrase: "identical kinase reaction conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(described above"

Phrase: ")"

Phrase: ","

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that ATP"

Phrase: "was"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.64: All determinations were done using two independent protein preparations and two independent phosphorylation reactions. 

Phrase: "All determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680730:determinations [Governmental or Regulatory Activity]
   966 E C1148554:determination [Laboratory Procedure]

Phrase: "were"

Phrase: "done"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two independent protein preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "two independent phosphorylation reactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0443286:Reaction [Functional Concept]
   779   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.65: Total substrate hydrolysis was less than 10%. 

Phrase: "Total substrate hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "less than 10%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]
Processing 00000000.tx.66: 6.8ng of EP24.15 (either phosphorylated or non-phosphorylated) was incubated at 37C with varying amounts of QFS or QF7 (4.4-17.6 M) in a final volume of 635l. 

Phrase: "6.8ng of EP24.15"

Phrase: "(either phosphorylated"

Phrase: "or"

Phrase: "non-phosphorylated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with varying amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of QFS"

Phrase: "or"

Phrase: "QF7"

Phrase: "(4.4-17.6"

Phrase: "M) in a final volume of 635l."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0205088:Final [Temporal Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0449468:*Volume [Quantitative Concept]
   748   C1546485:Final [Idea or Concept]
   748   C1690016:% volume [Qualitative Concept]
   748   C1705102:Volume [Intellectual Product]
   748   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.67: Kinetic parameters (Km, Vmax, kcat, and kcat/Km) were evaluated using the double-reciprocal plot method of Lineweaver and Burk (29). 

Phrase: "Kinetic parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "(Km,"

Phrase: "Vmax,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710637:Vmax [Phenomenon or Process]

Phrase: "kcat,"

Phrase: "and"

Phrase: "kcat/Km)"

Phrase: "were"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the double-reciprocal plot method of Lineweaver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Burk"

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.68: Kinetic Determinations Using Physiological Peptides GnRH, GnRH1-9, Bradykinin, and Neurotensin EP24.15 activity was determined under discontinuous assay conditions by quantification of substrate product peaks via high performance liquid chromatography as described previously (22) with modifications. 

Phrase: "Kinetic Determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Physiological Peptides GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "GnRH1-9,"

Phrase: "Bradykinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "and"

Phrase: "Neurotensin EP24.15 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined under discontinuous assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0439599:Discontinuous [Temporal Concept]
   770   C1444662:Discontinuous [Finding]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "conditions by quantification of substrate product"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0012634:condition [Disease or Syndrome]
   753   C0348080:Condition [Qualitative Concept]
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]
   753   C1705253:Condition [Conceptual Entity]
   753   C1709793:Quantification [Quantitative Concept]
   753   C1710236:Substrate [Manufactured Object]

Phrase: "peaks via high performance liquid chromatography"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   882   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   882   C1579831:High performance liquid chromatography [Functional Concept]
   790   C0008565:Liquid Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0205250:High [Qualitative Concept]
   753   C0302908:Liquid [Substance]
   753   C0444505:Peak [Quantitative Concept]
   753   C0597198:Performance [Individual Behavior]
   753   C1299351:High [Qualitative Concept]
   753   C1304698:Liquid [Finding]
   753   C1546699:Liquid NOS [Intellectual Product]
   753   C1561501:Liquid NOS [Substance]
   753   C1882330:Performance [Activity]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(22"

Phrase: ")"

Phrase: "with modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.69: 5-40 ng of EP24.15 (phosphorylated and non-phosphorylated) was incubated at 37C with varying concentrations of peptide substrate (11.2M to 1mM for GnRH, 10-100 M for GnRH1-9 and NT, and 2-100 M for bradykinin and bradykinin-amide). 

Phrase: "5-40 ng of EP24.15"

Phrase: "("

Phrase: "phosphorylated"

Phrase: "and"

Phrase: "non-phosphorylated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with varying concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of peptide substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "(11.2M to 1mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3171718:2M [Quantitative Concept]

Phrase: "for GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "10-100 M for GnRH1-9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "NT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "and"

Phrase: "2-100 M for bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "bradykinin-amide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002482:Amide [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.70: For NT assays, both cleavage products, NT1-8 and NT9-13, were used as standards. 

Phrase: "For NT assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "both cleavage products,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "NT1-8"

Phrase: "and"

Phrase: "NT9-13,"

Phrase: "were"

Phrase: "used as standards."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0038137:standards [Intellectual Product]
   790   C0175675:Standards [Qualitative Concept]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1442989:Standard [Qualitative Concept]
   756 E C1947944:Use [Intellectual Product]
   756 E C2828392:Standard [Intellectual Product]
Processing 00000000.tx.71: Total substrate hydrolysis was less than 10%. 

Phrase: "Total substrate hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "less than 10%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]
Processing 00000000.tx.72: Kinetic parameters were evaluated using Lineweaver and Burk plots (29). 

Phrase: "Kinetic parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lineweaver"

Phrase: "and"

Phrase: "Burk plots"

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.73: Determination of Enzyme Inhibitor Constants for cFP-AAF-pAB The inhibition constant of EP24.15 for the specific active site-directed inhibitor, cFP-AAF-pAB, was determined with 25ng of EP24.15 (either phosphorylated or non-phosphorylated) incubated at 37C with QFS (4.4M final concentration) and varying concentrations of cFP-AAF-pAB (0-100 nM) in reaction buffer (125mM NaCl, 0.3mM dithiothreitol, 25mM Tris-HCl, pH 7.5) in a final volume of 635l. 

Phrase: "Determination of Enzyme Inhibitor Constants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1148554:determination [Laboratory Procedure]

Phrase: "for cFP-AAF-pAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0083564:cFP-AAF-pAB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "The inhibition constant of EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1547014:*Constant [Quantitative Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1948059:Constant [Qualitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "for the specific active site-directed inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: "cFP-AAF-pAB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0083564:cFP-AAF-pAB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "determined with 25ng of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(either phosphorylated"

Phrase: "or"

Phrase: "non-phosphorylated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with QFS"

Phrase: "(4.4M final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "and"

Phrase: "varying concentrations of cFP-AAF-pAB (0-100 nM)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0086045:Concentrations [Mental Process]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "in reaction buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(125mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.3mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "25mM Tris-HCl,"

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 635l."
Processing 00000000.tx.74: Reactions were terminated after 30min by the addition of 115l of 0.5M sodium formate, pH 3.5.EP24.15 activities were determined as described above and the inhibition constant or Ki for phosphorylated and non-phosphorylated enzyme was evaluated using the method of Dixon (30). 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "terminated after 30min"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1553404:terminated [Idea or Concept]
   790   C2348570:Terminated [Functional Concept]
   718 E C0011065:Expired [Organism Function]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1704631:Expire [Idea or Concept]

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 115l"

Phrase: "of 0.5M sodium formate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0142851:sodium formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0016572:formate [Organic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0220832:formate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 3.5.EP24.15 activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   791   C0441655:Activities [Activity]
   758 E C0205177:Activity [Functional Concept]
   758 E C0439167:% activity [Quantitative Concept]
   758 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined as described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "the inhibition constant"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1547014:*Constant [Quantitative Concept]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C1948059:Constant [Qualitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "or"

Phrase: "Ki for phosphorylated"

Phrase: "and"

Phrase: "non-phosphorylated enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method of Dixon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.75: In Vivo Labeling and Immunoprecipitation Rat pheochromocytoma PC12 cells (grown as described previously, Ref. 17) and mouse pituitary AtT-20 cells (grown as described previously, Ref. 31) were cultured in 6-well plates (Nunc, Naperville, IL) until 70% confluent, serum-deprived for 10h in phosphate-free media (Mediatech, Herndon, VA), and incubated in pregassed phosphate-free Dulbecco's modified Eagle's medium containing 1mCi/ml of [32P]orthophosphate (PerkinElmer Life Sciences) for 6h. 

Phrase: "In Vivo Labeling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1167624:Labeling [Mental Process]
   827   C1947902:Labeling [Manufactured Object]
   827   C2827499:Labeling [Governmental or Regulatory Activity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "Immunoprecipitation Rat pheochromocytoma PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0085262:PC12 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "grown"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously,"

Phrase: "Ref. 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "mouse pituitary AtT-20 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0229535:Pituitary cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "grown"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously,"

Phrase: "Ref. 31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450355:31 [Intellectual Product]
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "cultured in 6-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(Nunc,"

Phrase: "Naperville,"

Phrase: "IL) until 70% confluent, serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0020898:IL [Geographic Area]
   760   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0022271:IL [Geographic Area]

Phrase: "deprived for 10h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442445:10H [Temporal Concept]

Phrase: "in phosphate-free media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "(Mediatech,"

Phrase: "Herndon,"

Phrase: "VA),"

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in pregassed phosphate-free Dulbecco's modified Eagle's medium containing 1mCi/ml of [32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C1553631:32p [Medical Device]

Phrase: "]orthophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "for 6h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292428:6H [Temporal Concept]
Processing 00000000.tx.76: For kinase activation/inhibition experiments, 100M forskolin (7-acetoxy-1,6,9-trihydroxy-8,13-epoxy-labd-14-en-11-one) was added 30min prior to harvesting, and 20M H89 (Calbiochem, La Jolla, CA), a PKA-selective inhibitor, was preincubated on cells for 4h prior to forskolin activation, respectively. 

Phrase: "For kinase activation/inhibition experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "100M forskolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(7-acetoxy-1,"

Phrase: "6,"

Phrase: "9-trihydroxy-8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1980007:Trihydroxy [Organic Chemical]

Phrase: "13-epoxy-labd-14-en-11-one)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "30min prior to harvesting,"

Phrase: "and"

Phrase: "20M H89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082782:h89 [Organic Chemical,Pharmacologic Substance]

Phrase: "(Calbiochem,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA),"

Phrase: "a PKA-selective inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   933   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   911   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   875   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   875   C3537023:kinase inhibitor [Molecular Function]
   875   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]
   717   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "preincubated on cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "for 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "prior to forskolin activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "respectively."
Processing 00000000.tx.77: EP24.15 was then immunoprecipitated as described previously (31) with the modification of RIPA buffer containing phosphatase inhibitors (10M sodium orthovanadate, 100nM fenvalerate, 1nM Microcystin-LR) (Calbiochem, La Jolla, CA) in the presence of 25l of the affinity purified anti-EP24.15 antibody (21). 

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "with the modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "of RIPA buffer containing phosphatase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   823   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(10M sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0029366:Orthovanadate [Inorganic Chemical]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "100nM fenvalerate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0877863:fenvalarate [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "1nM Microcystin-LR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0056661:microcystin-LR [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0023617:LR [Geographic Area]
   827   C0211296:Microcystin [Hazardous or Poisonous Substance,Pharmacologic Substance]
   827   C2986899:LR [Idea or Concept]

Phrase: ")"

Phrase: "(Calbiochem,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA) in the presence of 25l of the affinity"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "anti-EP24.15 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.78: Immunoprecipitation reactions were electrophoresed on an 8% SDS-polyacrylamide gel (23). 

Phrase: "Immunoprecipitation reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "electrophoresed on an 8% SDS-polyacrylamide gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   714   C0013855:electrophorese [Laboratory Procedure]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.79: Gels were dried under vacuum and exposed to film or phosphorscreen for further quantitation. 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "dried under vacuum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0042221:Vacuum [Natural Phenomenon or Process]
   790   C1512080:Dried [Qualitative Concept]
   790   C2827485:Dried [Body Substance]
   756 E C0011682:Dry [Natural Phenomenon or Process]
   756 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]

Phrase: "or"

Phrase: "phosphorscreen for further quantitation."
Processing 00000000.tx.80: Phosphoamino Acid Analysis Immunoprecipitated, 32P-labeled EP24.15 from either PC12 or AtT-20 cells, and in vitro PKA phosphorylated EP24.15 was extracted from SDS-PAGE gels (26). 

Phrase: "Phosphoamino Acid Analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0001128:Acid [Chemical]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "Immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ","

Phrase: "32P-labeled EP24.15 from either PC12"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0085262:PC-12 [Cell]
   739   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   739   C1553631:32p [Medical Device]
   739   C1708632:Labeled [Qualitative Concept]
   706 E C0181496:Label [Manufactured Object]
   706 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "or"

Phrase: "AtT-20 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "in vitro PKA phosphorylated EP24.15"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   816   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   809   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   809   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   801   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   801   C0021135:In Vitro [Intellectual Product]
   801   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   801   C1533691:in vitro [Qualitative Concept]
           vitro
   801   C2827718:In Vitro [Functional Concept]
   788   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "extracted from SDS-PAGE gels"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1704732:Page [Intellectual Product]
   760   C3541890:EXTRACTED [Finding]
   726 E C1382104:Gel [Substance]
   726 E C2828366:Extract [Substance]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.81: 200l of 6M HCl was added, tubes purged with nitrogen gas, capped, and then incubated at 110C for 1h (32). 

Phrase: "200l of 6M HCl"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "purged with nitrogen gas,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0301294:Nitrogen gas [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0017110:Gas [Chemical Viewed Structurally]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0596601:Gas [Sign or Symptom]
   770   C1548399:purged [Idea or Concept]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   737 E C0722910:Purge [Lipid,Pharmacologic Substance]

Phrase: "capped,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0179586:Cap [Manufactured Object]
   966   C1657858:CAP [Medical Device]
   966   C1706092:Cap [Medical Device]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated at 110C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.82: The hydrolyzed samples were dried by vacuum centrifugation. 

Phrase: "The hydrolyzed samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "dried by vacuum centrifugation."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0042221:Vacuum [Natural Phenomenon or Process]
   770   C1512080:Dried [Qualitative Concept]
   770   C2827485:Dried [Body Substance]
   737 E C0011682:Dry [Natural Phenomenon or Process]
   737 E C0205222:Dry [Qualitative Concept]
Processing 00000000.tx.83: Hydrolyzed amino acids were mixed with phosphoamino acid standards (Ser(P), Thr(P), and Tyr(P)) (ICN Biomedicals, Aurora, OH). 

Phrase: "Hydrolyzed amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "mixed with phosphoamino acid standards"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0001128:Acid [Chemical]
   760   C0038137:standards [Intellectual Product]
   760   C0175675:Standards [Qualitative Concept]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0205430:Mixed [Functional Concept]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1442989:Standard [Qualitative Concept]
   726 E C1720722:Mix [Qualitative Concept]
   726 E C2828392:Standard [Intellectual Product]

Phrase: "(Ser(P"

Phrase: ")"

Phrase: ","

Phrase: "Thr(P"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1421250:TYR [Gene or Genome]

Phrase: "(P)) (ICN Biomedicals,"

Phrase: "Aurora,"

Phrase: "OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.84: Samples were spotted on 2020-cm2 cellulose TLC plates (EM Science, Gibbstown, NJ), dried, and run at least 15cm in a proprionic acid, 1M NH4OH, isopropyl alcohol (45:17.5:17.5) solvent system (33). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "spotted on 2020-cm2 cellulose TLC plates"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   789   C0490502:PLATE, CELLULOSE, TLC [Medical Device]
   748   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   748   C0439479:cm2 [Quantitative Concept]
   748   C0555206:CM2 [Congenital Abnormality]
   748   C1139930:plates [Medical Device]
   714 E C0005971:Plate [Medical Device]
   714   C0329155:Spot [Fish]
   714   C1427618:SPOT [Gene or Genome]
   714   C1705203:Spot [Conceptual Entity]
   714 E C3537155:Plate [Manufactured Object]

Phrase: "(EM Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "Gibbstown,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "run at least 15cm"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035953:run [Daily or Recreational Activity]
   770   C0600140:run [Finding]
   770   C1704688:Run [Functional Concept]
   770   C2346414:Run [Finding]

Phrase: "in a proprionic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301670:Proprionic acid [Biologically Active Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "1M NH4OH,"

Phrase: "isopropyl alcohol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022237:Isopropyl Alcohol [Organic Chemical,Pharmacologic Substance]
   861   C0001962:ALCOHOL [Organic Chemical]
   861   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   861   C2945717:isopropyl [Chemical Viewed Structurally]
   789 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "(45"

Phrase: ":"

Phrase: "17.5"

Phrase: ":"

Phrase: "17.5"

Phrase: ")"

Phrase: "solvent system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.85: Amino acid standards were visualized using a ninhydrin spray (0.25% in acetone), and experimental phosphoamino acids visualized by autoradiography. 

Phrase: "Amino acid standards"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0038137:standards [Intellectual Product]
   827   C0175675:Standards [Qualitative Concept]
   793 E C1442989:Standard [Qualitative Concept]
   793 E C2828392:Standard [Intellectual Product]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a ninhydrin spray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704413:{Spray} [Quantitative Concept]
   861   C2003858:Spray [Functional Concept]

Phrase: "(0.25% in acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "experimental phosphoamino acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0524823:Phosphoamino Acids [Amino Acid, Peptide, or Protein]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.86: CNBr Cleavage of Phosphorylated EP24.15 In vitro phosphorylated EP24.15 was separated from free [-32P]ATP by Sephadex G75 gel filtration (Amersham Pharmacia Biotech, Piscataway, NJ). 

Phrase: "CNBr Cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "of Phosphorylated EP24.15 In vitro phosphorylated EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0021135:In Vitro [Intellectual Product]
   795   C1533691:in vitro [Qualitative Concept]
           vitro
   795   C2827718:In Vitro [Functional Concept]

Phrase: "was"

Phrase: "separated from free"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0086972:Separated [Finding]
   790   C0332296:free [Functional Concept]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   790   C1880497:Free [Qualitative Concept]
   790   C1996904:Free [Qualitative Concept]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP by Sephadex G75 gel filtration"

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.87: Crystalline cyanogen bromide was prepared in 70% trifluoroacetic acid, and cleavage performed (34). 

Phrase: "Crystalline cyanogen bromide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0010511:Cyanogen Bromide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0006222:Bromide [Inorganic Chemical]
   827   C0056658:cyanogen [Hazardous or Poisonous Substance,Inorganic Chemical]

Phrase: "was"

Phrase: "prepared in 70% trifluoroacetic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0040982:Trifluoroacetic Acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   726   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.88: Cleavage fragments were chromatographed on an analytical (0.650cm) Bio-Gel P10 Fine (Bio-Rad) column eluted isocratically in 0.1M ammonium bicarbonate (pH 8.0) under denaturing conditions at 0.5ml/min, 0.5-ml fractions were collected and radioactivity quantitated in a scintillation counter. 

Phrase: "Cleavage fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "chromatographed on an analytical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0936012:Analytical [Research Activity]
   737   C0302647:chromatograph [Medical Device]

Phrase: "(0.650cm"

Phrase: ")"

Phrase: "Bio-Gel P10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0966870:p10 [Amino Acid, Peptide, or Protein,Receptor]
   827   C1425194:p10 [Gene or Genome]
   827   C1548702:P10 [Intellectual Product]

Phrase: "Fine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205232:Fine [Qualitative Concept]
  1000   C0687757:fine [Regulation or Law]

Phrase: "(Bio-Rad) column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "eluted"

Phrase: "isocratically in 0.1M ammonium bicarbonate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0051706:ammonium bicarbonate [Organic Chemical,Pharmacologic Substance]
   753   C0002611:Ammonium [Inorganic Chemical]
   753   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   753   C0470296:1M [Quantitative Concept]
   753   C0973231:Bicarbonate [Inorganic Chemical]
   753   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "(pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "under denaturing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "at 0.5ml/min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "0.5-ml fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "quantitated in a scintillation counter."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0036405:Scintillation Counter [Medical Device]
   806   C1710025:Scintillation Counter [Manufactured Object]
   760   C0677601:Counter [Manufactured Object]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1705206:Counter [Medical Device]
Processing 00000000.tx.89: Mass estimates of cleavage fragments were deduced by a plot of the relative elution constant (ve/vo) versus log(MW) of calibrated molecular weight standards prior to, and after the sample was chromatographed. 

Phrase: "Mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0577559:Mass [Finding]
  1000   C1306372:*Mass [Quantitative Concept]
  1000   C3152252:Mass [Quantitative Concept]

Phrase: "estimates of cleavage fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0010813:cleavage [Cell Function]
   770   C0332255:fragments [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C0750572:Estimate [Quantitative Concept]
   770   C1330957:cleavage [Cell Function]
   737 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "deduced by a plot of the relative elution constant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1441565:Elution [Laboratory Procedure]
   742   C1547014:*Constant [Quantitative Concept]
   742   C1547039:*Relative [Quantitative Concept]
   742   C1948059:Constant [Qualitative Concept]

Phrase: "("

Phrase: "ve/"

Phrase: "vo)"

Phrase: "versus"

Phrase: "log"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708728:Log [Intellectual Product]
  1000   C2986775:log [Occupational Activity]

Phrase: "(MW) of calibrated molecular weight standards"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0024548:MW [Geographic Area]
   753   C0026385:mw [Quantitative Concept]
   753   C0556966:mW [Quantitative Concept]

Phrase: "prior to,"

Phrase: "and after the sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C1515981:And [Idea or Concept]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "chromatographed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0302647:chromatograph [Medical Device]
Processing 00000000.tx.90: Proteolytic Cleavage of Phosphorylated EP24.15 and MALDI-TOF Mass Spectrometry Trypsin and endoproteinase Lys-C (Roche Molecular Biochemicals, Indianapolis, IN) were reconstituted and incubated (as per the manufacturer's instructions) with in vitro phosphorylated EP24.15. 

Phrase: "Proteolytic Cleavage of Phosphorylated EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "MALDI-TOF Mass Spectrometry Trypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   771   C1518101:MALDI-TOF Mass Spectrometry [Research Activity]

Phrase: "and"

Phrase: "endoproteinase Lys-C (Roche Molecular Biochemicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C0205474:Biochemical [Functional Concept]

Phrase: "Indianapolis,"

Phrase: "IN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "were"

Phrase: "reconstituted"

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "("

Phrase: "as"

Phrase: "per the manufacturer's instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: ")"

Phrase: "with in vitro phosphorylated EP24.15."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0021135:In Vitro [Intellectual Product]
   812   C1533691:in vitro [Qualitative Concept]
           vitro
   812   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.91: The digested (phospho)peptides were desalted using a ZipTip (Millipore, Bedford, MA), divided into aliquots, and resuspended in 5l of 10mg/ml -cyano-4-hydroxycinnamic acid in 50% acetonitirile, 0.1% trifluoroacetic acid, with angiotensin as an internal standard. 

Phrase: "The digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "(phospho)peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "desalted"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a ZipTip"

Phrase: "(Millipore,"

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "divided into aliquots,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332849:Divided [Functional Concept]
   756   C1510844:Aliquot [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in 5l of 10mg/ml -cyano-4-hydroxycinnamic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0001128:Acid [Chemical]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0439526:/mL [Quantitative Concept]

Phrase: "in 50% acetonitirile,"

Phrase: "0.1% trifluoroacetic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "with angiotensin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "as an internal standard."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205102:Internal [Spatial Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]
   861   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.92: To further enhance detection of phosphorylated peptides, a portion of the peptide mixture was dissolved in a 1:1 1mM ammonium citrate/matrix solution (35). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "detection of phosphorylated peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "a portion of the peptide mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "dissolved in a 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1549535:Dissolve [Functional Concept]

Phrase: ":"

Phrase: "1 1mM ammonium citrate/matrix solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037633:Solution [Substance]
   799   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.93: Analyses were performed at the Howard Hughes Medical Institute, Columbia University Protein Facility (directed by Dr. Mary Ann Gawanowicz) on a MALDI-TOF mass spectrometer (Voyager-DE RP, PE-PerSeptive Biosystems) in the linear mode. 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed at the Howard Hughes Medical Institute,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0021622:institute [Organization]
   748   C0205476:Medical [Functional Concept]
   748   C0884358:Performed [Functional Concept]
   748   C1272753:Institute [Idea or Concept]
   748   C1551730:Hughes [Population Group]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Columbia University Protein Facility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1547538:Facility [Idea or Concept]

Phrase: "("

Phrase: "directed by Dr. Mary Ann Gawanowicz"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031831:DR [Professional or Occupational Group]
   753   C1707664:DR [Biomedical or Dental Material]
   753   C2348314:Dr. [Conceptual Entity]
   753   C3540849:DR [Idea or Concept]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: ")"

Phrase: "on a MALDI-TOF mass spectrometer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0183396:Mass Spectrometer [Medical Device]
   812   C0183395:Spectrometer [Medical Device]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C1710143:Spectrometer [Manufactured Object]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "(Voyager-DE RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1538326:RP [Gene or Genome]
   827   C3541325:RP [Idea or Concept]

Phrase: "PE-PerSeptive Biosystems"

Phrase: ")"

Phrase: "in the linear mode."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.94: Each mass spectrum was averaged from a minimum of 300measurements. 

Phrase: "Each mass spectrum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037813:Mass Spectrum [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "was"

Phrase: "averaged from a minimum of 300measurements."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1524031:Minimum [Qualitative Concept]
   753   C1552614:minimum [Idea or Concept]
   753   C2826545:MINIMUM [Quantitative Concept]
   719   C1510992:Average [Quantitative Concept]
   719   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.95: Controls for the cleavage of phosphorylated peptides included, in parallel, PKA without ATP added to EP24.15, and PKA alone to determine background signal. 

Phrase: "Controls for the cleavage of phosphorylated peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ","

Phrase: "in parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "PKA without ATP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "added to EP24.15,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524062:Added [Functional Concept]
   714 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "PKA alone to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "determine"

Phrase: "background signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.96: Only unique fragments generated upon phosphorylation of EP24.15 were considered in the analyses. 

Phrase: "Only unique fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "generated upon phosphorylation of EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "considered in the analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0750591:considered [Idea or Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
Processing 00000000.tx.97: Proteolytic cleavage sites used for mapping and miscuts were generated by the ExPASy Molecular Biology Server of the Swiss Institute of Bioinformatics (36, 37). 

Phrase: "Proteolytic cleavage sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "used for mapping"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C1283195:Mapping [Activity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "miscuts"

Phrase: "were"

Phrase: "generated by the ExPASy Molecular Biology Server of the Swiss Institute of Bioinformatics"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   750   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   735   C0005532:Biology [Biomedical Occupation or Discipline]
   735   C0021622:institute [Organization]
   735   C0241315:Swiss [Population Group]
   735   C0679792:server [Population Group]
   735   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]
   735   C1272753:Institute [Idea or Concept]
   735   C1521991:Molecular [Qualitative Concept]
   735   C1705194:Server [Manufactured Object]
   735   C3146294:Generated [Activity]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.98: Identification and Sequencing of Mouse EP24.15 cDNA A ZapII mouse pituitary cDNA library was purchased (Stratagene, La Jolla, CA) containing ~1.5106 recombinants and was screened as described previously with modifications (38). 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "Sequencing of Mouse EP24.15 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1553778:Sequencing [Intellectual Product]
   742   C1561491:Sequencing [Functional Concept]

Phrase: "A ZapII mouse pituitary cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   804   C0023621:Library [Manufactured Object,Organization]
   804   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "purchased"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0869011:purchased [Activity]

Phrase: "(Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA) containing ~1.5106 recombinants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1514798:Recombinants [Organism]

Phrase: "and"

Phrase: "was"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously with modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0392747:Modification [Functional Concept]
   756   C1554963:modification [Qualitative Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.99: After plaque formation, plates were overlaid first with one nitrocellulose filter (BA82 Schleicher and Schuell, Keene, NH), for 1min, and then a second filter was placed for 2min. 

Phrase: "After plaque formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "overlaid first with one nitrocellulose filter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205435:First [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]

Phrase: "(BA82 Schleicher"

Phrase: "and"

Phrase: "Schuell,"

Phrase: "Keene,"

Phrase: "NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "for 1min,"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "a second filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0180860:Filter [Manufactured Object]
   861   C0581406:Filter [Medical Device]
   861   C1522664:Filter [Intellectual Product]
   861   C1704449:Filter [Conceptual Entity]
   861   C1704684:Filter [Medical Device]
   861   C1875155:FILTER [Medical Device]

Phrase: "was"

Phrase: "placed for 2min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.100: These duplicate filters were probed with the entire coding sequence for the rat EP24.15 cDNA (36), labeled by random priming (Rediprime II, Amersham Pharmacia Biotech). 

Phrase: "These duplicate filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0180860:Filters [Manufactured Object]
   827 E C0581406:Filter [Medical Device]
   827 E C1522664:Filter [Intellectual Product]
   827 E C1704449:Filter [Conceptual Entity]
   827 E C1704684:Filter [Medical Device]
   827 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "probed with the entire coding sequence"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0079941:Coding Sequence [Gene or Genome]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0009219:Coding [Occupational Activity]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0439751:Entire [Quantitative Concept]
   753   C0444667:Entire [Quantitative Concept]
   753   C1519249:Sequence [Functional Concept]
   719   C0182400:Probe [Medical Device]
   719 E C0805701:Code [Intellectual Product]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "for the rat EP24.15 cDNA (36"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0034693:Rat, NOS [Mammal]
   793   C0034721:Rat [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "labeled by random priming"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0034656:RANDOM [Research Activity]
   770   C0439605:Random [Qualitative Concept]
   770   C0871133:Priming [Functional Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Rediprime II,"

Phrase: "Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.101: Filters were washed stringently to 0.1SSC, 0.1% SDS, 65C. 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "stringently to 0.1SSC,"

Phrase: "0.1% SDS,"

Phrase: "65C."
Processing 00000000.tx.102: From the first screen (~2.8106 plaques), 27positive plaques were identified. 

Phrase: "From the first screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220908:screen [Health Care Activity]
   861   C1305399:screen [Functional Concept]
   861   C1705053:Screen [Medical Device]

Phrase: "(~2.8106 plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: ")"

Phrase: ","

Phrase: "27positive plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.103: Subsequent rescreening produced 14positive plaques which were purified, and placed through a tertiary screen. 

Phrase: "Subsequent rescreening produced 14positive plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0333463:plaques [Acquired Abnormality]
   771 E C0011389:Plaque [Disease or Syndrome]
   771 E C0332461:Plaque [Finding]

Phrase: "which"

Phrase: "were"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "and"

Phrase: "placed through a tertiary screen."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205372:Tertiary [Quantitative Concept]
   760   C0220908:screen [Health Care Activity]
   760   C1305399:screen [Functional Concept]
   760   C1705053:Screen [Medical Device]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.104: Bluescript plasmid containing the cloned inserts were excised by superinfection with R408 helper phage (36). 

Phrase: "Bluescript plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the cloned inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0813036:Inserts [Medical Device]
   827 E C0441587:Insert [Health Care Activity]
   827 E C1743766:Insert [Medical Device]
   827 E C1883719:Insert [Functional Concept]

Phrase: "were"

Phrase: "excised by superinfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0038826:Superinfection [Disease or Syndrome]

Phrase: "with R408 helper phage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004651:Phage [Virus]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.105: cDNA inserts ranged in size from 1.1to 2.3kilobases. 

Phrase: "cDNA inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0813036:Inserts [Medical Device]
   827 E C0441587:Insert [Health Care Activity]
   827 E C1743766:Insert [Medical Device]
   827 E C1883719:Insert [Functional Concept]

Phrase: "ranged in size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0456389:size [Spatial Concept]
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "from 1.1to 2.3kilobases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0580272:1/2 [Intellectual Product]
   708   C1519043:1-2 [Research Activity]
Processing 00000000.tx.106: Restriction analysis and probing with 5' and 3' random primed labeled cDNA fragments indicated that one of the clones contained a full-length insert. 

Phrase: "Restriction analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "probing with 5'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0419358:Probing, NOS [Diagnostic Procedure]

Phrase: "and"

Phrase: "3' random primed labeled cDNA fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that one of the clones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a full-length insert."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441587:Insert [Health Care Activity]
   827   C1743766:Insert [Medical Device]
   827   C1883719:Insert [Functional Concept]
Processing 00000000.tx.107: This clone was sequenced in both directions using the ABI Bigdye terminator sequencing kit (PerkinElmer Life Sciences, South Plainfield, NJ). 

Phrase: "This clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "sequenced in both directions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0439755:Directions [Spatial Concept]
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737 E C0449738:Direction [Spatial Concept]
   737   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ABI Bigdye terminator sequencing kit (PerkinElmer Life Sciences,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0005526:Life Sciences [Occupation or Discipline]
   793   C0036397:Sciences [Occupation or Discipline]
   793   C0376558:Life [Idea or Concept]
   710 E C0595998:lives [Finding]

Phrase: "South Plainfield,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.108: Data were analyzed using ABI Sequencing Analysis 3.3(PerkinElmer Life Sciences), and Sequencher 3.1.1(Gene Codes, Ann Arbor, MI) computer programs. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ABI Sequencing Analysis 3.3"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   823   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1328319:ABI [Clinical Attribute]
   804   C1524024:analysis [Functional Concept]
   804   C1553778:Sequencing [Intellectual Product]
   804   C1561491:Sequencing [Functional Concept]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162326:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Sequencher 3.1.1"

Phrase: "(Gene Codes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0919279:codes [Classification]
   827 E C0009219:code [Occupational Activity]
   827 E C0805701:Code [Intellectual Product]

Phrase: "Ann Arbor,"

Phrase: "MI) computer programs."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0037585:Computer Programs [Intellectual Product,Manufactured Object]
   827   C0376691:Programs [Intellectual Product]
   827   C3484370:Programs [Functional Concept]
   793 E C1709697:Program [Conceptual Entity]
   793 E C2728259:Program [Pharmacologic Substance]
Processing 00000000.tx.109: Sequence alignments were made with the CLUSTAL program (39).  

Phrase: "Sequence alignments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0080143:Sequence Alignments [Molecular Biology Research Technique]
   827   C1706765:Alignment [Quantitative Concept]

Phrase: "were"

Phrase: "made with the CLUSTAL program"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]
   726   C1881534:Make [Functional Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.110: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES EP24.15 Is a Substrate for PKA Phosphorylation-- Examination of the EP24.15 primary sequence revealed putative consensus phosphorylation sites (20), including those for PKA, PKC, and CKII (refer to Fig. 5). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Is"

Phrase: "a Substrate for PKA Phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710236:Substrate [Manufactured Object]

Phrase: "--"

Phrase: "Examination of the EP24.15 primary sequence"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "putative consensus phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C1519063:Phosphorylation Site [Amino Acid Sequence]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0205145:Sites [Spatial Concept]
   812   C1158886:Phosphorylation [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those for PKA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "and"

Phrase: "CKII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707154:CKII [Gene or Genome]

Phrase: "("

Phrase: "refer to Fig. 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205543:refer [Functional Concept]
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.111: These motifs suggested that EP24.15 could be a potential substrate for phosphorylation. 

Phrase: "These motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514562:Motif [Amino Acid Sequence]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "could"

Phrase: "be"

Phrase: "a potential substrate for phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.112: To test this hypothesis, rat recombinant EP24.15 and control substrates were incubated with various protein kinases. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "rat recombinant EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]
   795   C1514798:recombinant [Organism]

Phrase: "and"

Phrase: "control substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "incubated with various protein kinases."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.113: Whereas the incubation of EP24.15 with PKC (both and isotypes) and CKII did not cause incorporation of phosphate into the protein (versus positive control subtrates) (Fig. 1A), incubation with PKA yielded a rapid and saturable incorporation of phosphate at the correct mass of 77kDa (Fig. 1B). 

Phrase: "Whereas"

Phrase: "the incubation of EP24.15"

Phrase: "with PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "("

Phrase: "both"

Phrase: "and"

Phrase: "isotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021017:isotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "and"

Phrase: "CKII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707154:CKII [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "incorporation of phosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243126:incorporation [Functional Concept]

Phrase: "into the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "versus"

Phrase: "positive control subtrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883676:Positive Control [Conceptual Entity]

Phrase: ")"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "incubation with PKA"

Phrase: "yielded"

Phrase: "a rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "saturable incorporation of phosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "at the correct mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "of 77kDa"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: The phosphorylated residue was confirmed to be serine by phosphoamino acid analysis (Fig. 1C). 

Phrase: "The phosphorylated residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "serine by phosphoamino acid analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.115: This incorporation yielded an overall stoichiometry of 1.110.12mol of phosphate/mol of EP24.15, consistent with one primary site of phosphate incorporation. 

Phrase: "This incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243126:incorporation [Functional Concept]

Phrase: "yielded"

Phrase: "an overall stoichiometry of 1.110.12mol of phosphate/mol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "of EP24.15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "consistent with one primary site of phosphate incorporation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.116: A time course of phosphorylation performed (see "Experimental Procedures") from 15to 240min indicated that saturation of incorporated label occurred within 90min (data not shown) under the assay conditions. 

Phrase: "A time course of phosphorylation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0449247:Time course [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0750729:Course [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: "from 15to 240min"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that saturation of incorporated label"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522534:Saturation [Phenomenon or Process]

Phrase: "occurred within 90min"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "under the assay conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.117: To ensure saturable labeling conditions, components of the kinase reaction were varied in an attempt to increase the molar ratio (Table I). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "saturable labeling conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "components of the kinase reaction"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "varied in an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1516084:Attempt [Event]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the molar ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2825550:Molar Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.118: Doubling the ATP concentration, PKA concentration, and priming the reaction with additional PKA at 90min did not effect the stoichiometry of the reaction. 

Phrase: "Doubling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205173:doubling [Functional Concept]
  1000   C1705764:Doubling [Activity]
   966 E C1705765:Double [Qualitative Concept]

Phrase: "the ATP concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "PKA concentration,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   902   C0427716:Protein concentration [Laboratory Procedure]
   902   C1304757:Protein concentration [Laboratory or Test Result]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   741 E C1880165:Concentrated [Biomedical or Dental Material]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "priming"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:Priming [Functional Concept]

Phrase: "the reaction with additional PKA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]

Phrase: "at 90min"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "the stoichiometry of the reaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597526:Stoichiometry [Quantitative Concept]
Processing 00000000.tx.119: These results suggested that the system was at saturation for subsequent kinetic analyses. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "was at saturation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0522534:Saturation [Phenomenon or Process]
   790   C1421478:WAS [Gene or Genome]
   718 E C1705188:SATURATED [Quantitative Concept]

Phrase: "for subsequent kinetic analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
Processing 00000000.tx.120: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.121: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.122: EP24.15 is a substrate for PKA phosphorylation. 

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a substrate for PKA phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.123: A, all kinases for which putative sites exist in the EP24.15 sequence were assayed under appropriate conditions as outlined under "Experimental Procedures." 

Phrase: "A,"

Phrase: "all kinases for which putative sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "exist in the EP24.15 sequence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]
   742   C2987476:Exist [Conceptual Entity]

Phrase: "were"

Phrase: "assayed under appropriate conditions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1548787:Appropriate [Qualitative Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0012634:condition [Disease or Syndrome]
   737   C0243073:assay [Qualitative Concept]
   737   C0348080:Condition [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "as"

Phrase: "outlined under ""Experimental Procedures."""
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.124: Only PKA exhibited any significant incorporation of phosphate. 

Phrase: "Only PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "any significant incorporation of phosphate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.125: B, autoradiograph of EP24.15 incubated with PKA and [-32P]ATP. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "autoradiograph of EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986957:Autoradiograph [Manufactured Object]

Phrase: "incubated with PKA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "and [-"

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP."
Processing 00000000.tx.126: PKA also undergoes autophosphorylation to a small degree (lower band). 

Phrase: "PKA also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "undergoes"

Phrase: "autophosphorylation to a small degree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0813988:autophosphorylation [Molecular Function]

Phrase: "(lower band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: ")."
Processing 00000000.tx.127: C, in vitro PKA-phosphorylated EP24.15 was subjected to phosphoamino acid analysis as outlined under "Experimental Procedures," and exhibited only serine residue phosphorylation. 

Phrase: "C,"

Phrase: "in vitro PKA-phosphorylated EP24.15"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   816   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   809   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   809   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   801   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   801   C0021135:In Vitro [Intellectual Product]
   801   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   801   C1533691:in vitro [Qualitative Concept]
           vitro
   801   C2827718:In Vitro [Functional Concept]
   788   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "subjected to phosphoamino acid analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "outlined under ""Experimental Procedures,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: """"

Phrase: "and"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "only serine residue phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.128: 1,expressed as moles of phosphate per mole of EP24.15. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "expressed as moles of phosphate"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0027960:Moles [Neoplastic Process]
   760   C0027962:moles [Neoplastic Process]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0324740:Moles [Mammal]
   760   C1456781:moles [Neoplastic Process]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0439189:Mole [Quantitative Concept]

Phrase: "per mole"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   928 E C0026367:Molar [Body Part, Organ, or Organ Component]
   893 E C0027962:moles [Neoplastic Process]

Phrase: "of EP24.15."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.129: 2,no incorp., <0.1 mol/phosphate/mol of EP24.15 incorporated.  

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "no incorp.,"

Phrase: "<0.1 mol/phosphate/mol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   853   C2347289:Mole/Mole [Quantitative Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "incorporated."
Processing 00000000.tx.130: View this table: [in this window] [in a new window]  Table I PKA phosphorylation of EP24.15 is saturable In vitro phosphorylation conditions were altered in an attempt to further saturate EP24.15 phosphorylation site(s) (see "Experimental Procedures"). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I PKA phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]

Phrase: "of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "saturable In vitro phosphorylation conditions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   771   C0012634:condition [Disease or Syndrome]
   771   C0348080:Condition [Qualitative Concept]
   771   C1705253:Condition [Conceptual Entity]
   721 E C0009647:Conditioned [Mental Process]
   721 E C1701901:Conditional [Qualitative Concept]
   721 E C1963686:Conditional [Functional Concept]

Phrase: "were"

Phrase: "altered in an attempt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Altered [Functional Concept]
   770   C1516084:Attempt [Event]

Phrase: "to further saturate EP24.15 phosphorylation site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C1519063:Phosphorylation Site [Amino Acid Sequence]
   791   C0031715:Phosphorylation [Molecular Function]
   791   C0205145:Site [Spatial Concept]
   791   C1158886:Phosphorylation [Molecular Function]
   791   C1515974:Site [Body Location or Region]
   791   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "s) ("

Phrase: "see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: Phosphorylation of EP24.15 Introduces Alterations in Enzyme Kinetic Parameters-- The possibility that PKA phosphorylation of EP24.15 may effect kinetic parameters toward various substrates was examined. 

Phrase: "Phosphorylation of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "Introduces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:Introduces [Functional Concept]

Phrase: "Alterations in Enzyme Kinetic Parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The possibility"

Phrase: "that PKA phosphorylation of EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   738   C0031715:Phosphorylation [Molecular Function]

Phrase: "may"

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "kinetic parameters toward various substrates"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.132: A significant 46% decrease in the specificity constant was observed for the QF7 fluorimetric substrate (18105 M1 s1 versus 10105 M1 s1, n=4,p<0.05) upon PKA phosphorylation. 

Phrase: "A significant 46% decrease in the specificity constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed for the QF7 fluorimetric substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1441672:Observed [Functional Concept]
   753   C1710236:Substrate [Manufactured Object]

Phrase: "(18105 M1 s1"

Phrase: "versus"

Phrase: "10105 M1 s1,"

Phrase: "n=4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "upon PKA phosphorylation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   812   C0031715:Phosphorylation [Molecular Function]
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.133: Another fluorimetric substrate was examined (QFS, see Table II), and following phosphorylation, a 44% decrease in the specificity constant (kcat/Km) was observed, nearly identical to the result seen with QF7. 

Phrase: "Another fluorimetric substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(QFS,"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table II"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "a 44% decrease in the specificity constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "(kcat/Km)"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "nearly identical to the result"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "seen with QF7."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.134: Similarly, a 38% decrease in the specificity constant was observed for GnRH1-9 (p<0.09). 

Phrase: "Similarly,"

Phrase: "a 38% decrease in the specificity constant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed for GnRH1-9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "(p<0.09"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.135: The specificity constant of neurotensin also decreased, and indicated the same trend, but was not significant.  

Phrase: "The specificity constant of neurotensin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1547014:*Constant [Quantitative Concept]
   753   C1948059:Constant [Qualitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the same trend,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521798:trend [Temporal Concept]

Phrase: "but"

Phrase: "was"

Phrase: "not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.136: View this table: [in this window] [in a new window]  Table II EP24.15 kinetic parameters for various substrates upon in vitro PKA phosphorylation GnRH, GnRH1-9, and QFS assays are outlined under "Experimental Procedures." 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II EP24.15 kinetic parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   791   C0449381:Parameters [Finding]
   758 E C0549193:Parameter [Spatial Concept]
   758 E C1704769:Parameter [Conceptual Entity]
   758 E C2350001:Parameter [Quantitative Concept]

Phrase: "for various substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "upon in vitro PKA phosphorylation GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "GnRH1-9,"

Phrase: "and"

Phrase: "QFS assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "are"

Phrase: "outlined under ""Experimental Procedures."""
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.137: QFS and NT are n=2 (S.E.) independent determinations. 

Phrase: "QFS"

Phrase: "and"

Phrase: "NT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "are"

Phrase: "n=2 ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "S."

Phrase: "E.) independent determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.138: GnRH1-9 is n=4 (S.E.) independent determinations, and GnRH is n=3 (S.E.) independent determinations. 

Phrase: "GnRH1-9"

Phrase: "is"

Phrase: "n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "("

Phrase: "S."

Phrase: "E.) independent determinations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "GnRH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "is"

Phrase: "n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "("

Phrase: "S."

Phrase: "E.) independent determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.139: The colon (:) indicates bond cleaved. 

Phrase: "The colon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009368:Colon [Body Part, Organ, or Organ Component]
  1000   C1281569:Colon [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: ":"

Phrase: ")"

Phrase: "indicates"

Phrase: "bond"

Phrase: "cleaved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]
Processing 00000000.tx.140: Strikingly, phosphorylation caused a 7-fold increase in the Km and kcat (with the corresponding increase in Vmax) parameters measured for GnRH (Table II). 

Phrase: "Strikingly,"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 7-fold increase in the Km"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "kcat (with the corresponding increase"

Phrase: "in Vmax) parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "measured for GnRH"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.141: The possibility that the 7-fold increases observed with the kinetic values for GnRH (not seen with GnRH1-9) were a function of a newly formed charge interaction between the COOH-terminal residue on the peptide and the phosphate group on EP24.15 was investigated. 

Phrase: "The possibility"

Phrase: "that"

Phrase: "the 7-fold increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:increases [Functional Concept]

Phrase: "observed with the kinetic values"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0022702:kinetic [Natural Phenomenon or Process]
   760   C0042295:Values [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   726 E C1522609:Value [Quantitative Concept]
   704 E C0026597:Motion [Natural Phenomenon or Process]
   704 E C0687704:Motions [Functional Concept]

Phrase: "for GnRH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen with GnRH1-9"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: ")"

Phrase: "were"

Phrase: "a function of a newly formed charge interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "between the COOH-terminal residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "on the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "the phosphate group on EP24.15"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0441869:Group 3 [Intellectual Product]
   762   C0441876:Group 4 [Intellectual Product]
   742   C0441833:Group [Idea or Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1552516:Group [Health Care Related Organization]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.142: Another EP24.15 substrate, bradykinin (RPPGFSPFR), and a synthetic bradykinin analog containing an amide-blocked COOH terminus (RPPGFSPFR-NH2) were used for similar kinetic analyses. 

Phrase: "Another EP24.15 substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1710236:Substrate [Manufactured Object]

Phrase: "bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "(RPPGFSPFR"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a synthetic bradykinin analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an amide-blocked COOH terminus"

Phrase: "(RPPGFSPFR-NH2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002508:NH2 [Organic Chemical]
   861   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "used for similar kinetic analyses."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C0022702:kinetic [Natural Phenomenon or Process]
   760   C1273517:used [Finding]
   760   C2348205:Similar [Qualitative Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   704 E C0026597:Motion [Natural Phenomenon or Process]
   704 E C0687704:Motions [Functional Concept]
Processing 00000000.tx.143: The carboxyl-terminal charge of these substrates were analogous to GnRH1-9 and GnRH, respectively. 

Phrase: "The carboxyl-terminal charge of these substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0007961:Charge [Quantitative Concept]
   748   C1706211:Charge [Organism Attribute]

Phrase: "were"

Phrase: "analogous to GnRH1-9"

Phrase: "and"

Phrase: "GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.144: Following phosphorylation, the Km of EP24.15 for bradykinin increased from 3.8to 13M upon phosphorylation, while for bradykinin-amide it decreased from 82to 50M, and thus did not replicate the findings for GnRH. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "the Km of EP24.15"

Phrase: "for bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "increased from 3.8to 13M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "upon phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "while for bradykinin-amide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002482:Amide [Organic Chemical]
   770   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   770   C0750519:while [Idea or Concept]
   770   C1537501:bradykinin [Gene or Genome]

Phrase: "it"

Phrase: "decreased from 82to 50M,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "replicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "the findings for GnRH."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]
Processing 00000000.tx.145: To examine whether the alterations in the kinetic parameters of EP24.15 for GnRH were caused by a change in active site accessibility due to phosphorylation, the Ki was determined with an EP24.15-specific active site-directed inhibitor, cFP-AAF-pAB, the design of which is based on the hydrophobic and spatial considerations of the GnRH peptide structure (40). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the alterations in the kinetic parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "for GnRH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "were"

Phrase: "caused by a change in active site accessibility"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0205681:Active Site [Functional Concept]
   744   C0205145:Site [Spatial Concept]
   744   C0205177:Active [Functional Concept]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C0814423:accessibility [Qualitative Concept]
   744   C1515974:Site [Body Location or Region]
   744   C1705241:Change [Quantitative Concept]
   744   C2825164:Site [Spatial Concept]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]

Phrase: "due to phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "the Ki"

Phrase: "was"

Phrase: "determined"

Phrase: "with an EP24.15-specific active site-directed inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999216:Inhibitor [Qualitative Concept]

Phrase: "cFP-AAF-pAB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0083564:cFP-AAF-pAB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "the design of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "is"

Phrase: "based on the hydrophobic"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0598629:Hydrophobic [Qualitative Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "spatial considerations of the GnRH peptide structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0518609:considerations [Finding]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.146: The Ki of the nonphosphorylated enzyme was 240.5versus 210.7nM upon PKA phosphorylation, values consistent with both the recombinant enzyme (38) and rat brain-purified enzyme (40). 

Phrase: "The Ki of the nonphosphorylated enzyme"

Phrase: "was"

Phrase: "240.5versus 210.7nM upon PKA phosphorylation,"

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "consistent with both"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "the recombinant enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(38"

Phrase: ")"

Phrase: "and"

Phrase: "rat brain-purified enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.147: Determination of the PKA Phosphorylation Site-- To determine which serine was the primary site for PKA phosphorylation, a series of mutant enzymes were designed, expressed, and assayed. 

Phrase: "Determination of the PKA Phosphorylation Site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1148554:determination [Laboratory Procedure]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "the primary site for PKA phosphorylation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0449695:Primary site [Spatial Concept]
   767   C1519063:Phosphorylation Site [Amino Acid Sequence]
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "a series of mutant enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: ","

Phrase: "expressed"

Phrase: ","

Phrase: "and"

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.148: Each of the putative PKA sites were systematically altered by site-directed mutagenesis, generating the following mutants: S98A, S106A, S172A, S288A, S398A, S522A, and S644A. 

Phrase: "Each of the putative PKA sites"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   800   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   750   C2945843:Site of [Qualitative Concept]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205145:Sites [Spatial Concept]
   744   C1457900:Each [Quantitative Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "systematically"

Phrase: "altered by site-directed mutagenesis,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   760   C0079866:Mutagenesis [Molecular Function]
   760   C0205145:Site [Spatial Concept]
   760   C0392747:Altered [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   760   C3146302:Mutagenesis [Laboratory Procedure]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "generating"

Phrase: "the following mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "S98A,"

Phrase: "S106A,"

Phrase: "S172A,"

Phrase: "S288A,"

Phrase: "S398A,"

Phrase: "S522A,"

Phrase: "and"

Phrase: "S644A."
Processing 00000000.tx.149: Under identical PKA reaction conditions, phosphate incorporation in the mutants was indistinguishable from wild type, with the exception of the S644A mutant, which revealed negligible phosphate incorporation (Fig. 2A). 

Phrase: "Under identical PKA reaction conditions,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   766   C0012634:condition [Disease or Syndrome]
   766   C0348080:Condition [Qualitative Concept]
   766   C1705253:Condition [Conceptual Entity]
   716 E C0009647:Conditioned [Mental Process]
   716 E C1701901:Conditional [Qualitative Concept]
   716 E C1963686:Conditional [Functional Concept]

Phrase: "phosphate incorporation in the mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "indistinguishable from wild type,"

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of the S644A mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "negligible phosphate incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243126:incorporation [Functional Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.150: PhosphorImager quantification of the bands indicated an approximate 95% decline in the incorporation of phosphate (after normalization of the Coomassie stain using scanning densitometry) as compared with the wild type enzyme. 

Phrase: "PhosphorImager quantification of the bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "an approximate 95% decline in the incorporation of phosphate"

Phrase: "("

Phrase: "after normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "of the Coomassie stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "scanning densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011321:Densitometry [Laboratory Procedure]

Phrase: ")"

Phrase: "as"

Phrase: "compared with the wild type enzyme."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.151: To ensure that the amino acid substitution did not cause perturbations with respect to the correct folding of the protein (41), all of the mutants were analyzed by native gel electrophoresis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the amino acid substitution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0525038:Amino Acid Substitution [Genetic Function,Molecular Biology Research Technique]
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "perturbations with respect to the correct folding of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0332453:perturbation [Functional Concept]

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "all of the mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C0596988:mutants [Cell or Molecular Dysfunction]
   770   C3539085:All [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by native gel electrophoresis."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0302891:Native [Functional Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1382104:Gel [Substance]
Processing 00000000.tx.152: No changes in mobility nor protein expression were observed as compared with the wild type enzyme (data not shown). 

Phrase: "No changes in mobility"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C0442739:No change [Finding]
   816   C1548568:No change [Intellectual Product]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "nor"

Phrase: "protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "as"

Phrase: "compared with the wild type enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.153: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.154: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.155: Determination of the in vitro PKA phosphorylation site. 

Phrase: "Determination of the in vitro PKA phosphorylation site."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.156: A, mutation of serine 644to alanine caused a dramatic decrease in the incorporation of phosphate into EP24.15. 

Phrase: "A,"

Phrase: "mutation of serine 644to alanine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a dramatic decrease in the incorporation of phosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "into EP24.15."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.157: B, typical elution profile of CNBr-cleaved EP24.15 (phosphorylated using [-32P]ATP) on a calibrated Bio-Gel P10-fine column. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "typical elution profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "of CNBr-cleaved EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0010511:CNBr [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   795   C0205242:Cleaved [Spatial Concept]
   795   C0333853:Cleaved [Cell]

Phrase: "("

Phrase: "phosphorylated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: ")"

Phrase: "on a calibrated Bio-Gel P10-fine column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1185738:Column [Body Part, Organ, or Organ Component]
   799   C1706132:Column [Idea or Concept]
Processing 00000000.tx.158: C, Lys-C and trypsin digestions of PKA-phosphorylated EP24.15 were subjected to MALDI-TOF as outlined under "Experimental Procedures." 

Phrase: "C,"

Phrase: "Lys-C"

Phrase: "and"

Phrase: "trypsin digestions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2348822:Trypsin Digestion [Research Activity]
   861   C0012238:digestions [Organism Function]
   827 E C2349986:Digestion [Research Activity]
   789 E C0443277:Peptic [Functional Concept]

Phrase: "of PKA-phosphorylated EP24.15"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   807   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "subjected to MALDI-TOF"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1518101:MALDI-TOF [Research Activity]
   770   C0039685:TOF [Congenital Abnormality]
   770   C0282597:MALDI [Laboratory Procedure]
   770   C1825291:TOF [Gene or Genome]
   770   C2348791:TOF [Quantitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "outlined under ""Experimental Procedures."""
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.159: Cyanogen bromide cleavage of PKA-phosphorylated EP24.15 (using [-32P]ATP) was subjected to size-exclusion chromatography on a calibrated Bio-Gel P10-fine column, and then the fractions counted. 

Phrase: "Cyanogen bromide cleavage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0010511:Cyanogen Bromide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0006222:Bromide [Inorganic Chemical]
   827   C0010813:cleavage [Cell Function]
   827   C0056658:cyanogen [Hazardous or Poisonous Substance,Inorganic Chemical]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "of PKA-phosphorylated EP24.15"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   807   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: ")"

Phrase: "was"

Phrase: "subjected to size-exclusion chromatography"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "on a calibrated Bio-Gel P10-fine column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1185738:Column [Body Part, Organ, or Organ Component]
   799   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.160: Serine 644is indicated in the gray shaded box for each fragment. 

Phrase: "Serine 644is"

Phrase: "indicated in the gray shaded box"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0179400:Box [Manufactured Object]
   753   C0556636:gray [Quantitative Concept]
   753   C1269776:Gray [Qualitative Concept]
   753   C1444656:Indicated [Finding]
   753   C1533124:Box [Medical Device]

Phrase: "for each fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.161: Masses expressed in daltons. 

Phrase: "Masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0577559:Mass [Finding]
   966   C1306372:*Mass [Quantitative Concept]
   966   C3152252:Mass [Quantitative Concept]

Phrase: "expressed in daltons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0678223:dalton [Quantitative Concept]
Processing 00000000.tx.162: To further confirm that the phosphorylation site on EP24.15 was serine 644,PKA phosphorylated enzyme was prepared using [-32P]ATP and then cleaved by cyanogen bromide. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the phosphorylation site on EP24.15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1519063:Phosphorylation Site [Amino Acid Sequence]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0205145:Site [Spatial Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "serine 644,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "PKA phosphorylated enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]
   717   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cleaved by cyanogen bromide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0010511:Cyanogen Bromide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0056658:cyanogen [Hazardous or Poisonous Substance,Inorganic Chemical]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
Processing 00000000.tx.163: This treatment yielded a phosphorylated 2-kDa fragment which was detectable by scintillation counting of fractions eluted from a size exclusion chromatography column calibrated before and after the CNBr-cleaved fragments were separated (Fig. 2B). 

Phrase: "This treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "yielded"

Phrase: "a phosphorylated 2-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "detectable by scintillation counting of fractions"

Phrase: "eluted from a size exclusion chromatography column"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   814   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   778   C0684296:Chromatography.column [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0456389:size [Spatial Concept]
   748   C0680251:EXCLUSION [Functional Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]
   748   C2828389:Exclusion [Activity]

Phrase: "calibrated before"

Phrase: "and after the CNBr-cleaved fragments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0010511:CNBr [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   753   C0205242:Cleaved [Spatial Concept]
   753   C0332255:fragments [Functional Concept]
   753   C0333853:Cleaved [Cell]
   753   C0486805:Fragments [Body Substance]
   753   C1515981:And [Idea or Concept]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.164: The 2-kDa fragment uniquely and unambiguously assigned the fragment to residues 640-657 (1987daltons) (Fig. 2C). 

Phrase: "The 2-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "uniquely"

Phrase: "and"

Phrase: "unambiguously"

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "the fragment to residues 640-657"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "(1987daltons"

Phrase: ")"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.165: Furthermore, phosphorylated and non-phosphorylated enzyme was prepared (see "Experimental Procedures"), and subjected to specific (trypsin and Lys-C) proteolytic cleavage and mass analysis by MALDI-TOF mass spectrometry. 

Phrase: "Furthermore,"

Phrase: "phosphorylated"

Phrase: "and"

Phrase: "non-phosphorylated enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "subjected to specific"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "(trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "Lys-C) proteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "mass analysis by MALDI-TOF mass spectrometry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.166: Lys-C digestion yielded a peptide whose mass (2484daltons) corresponded to the fragment 637-659 with the addition of a +80-dalton phosphate moiety (Fig. 2C). 

Phrase: "Lys-C digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0012238:Digestion [Organism Function]
   827   C2349986:Digestion [Research Activity]
   771 E C0443277:Peptic [Functional Concept]

Phrase: "yielded"

Phrase: "a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "whose mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0577559:Mass [Finding]
  1000   C1306372:*Mass [Quantitative Concept]
  1000   C3152252:Mass [Quantitative Concept]

Phrase: "(2484daltons"

Phrase: ")"

Phrase: "corresponded to the fragment 637-659"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "with the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of a +80-dalton phosphate moiety"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.167: Trypsin digestion of PKA-phosphorylated EP24.15 yielded a peptide whose mass (1846daltons) corresponded closely to fragment 643-659 with the addition of a +80-dalton phosphate moiety (an actual addition of 84daltons) (Fig. 2C). 

Phrase: "Trypsin digestion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2348822:Trypsin Digestion [Research Activity]
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]

Phrase: "of PKA-phosphorylated EP24.15"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   817   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   807   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "yielded"

Phrase: "a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "whose mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0577559:Mass [Finding]
  1000   C1306372:*Mass [Quantitative Concept]
  1000   C3152252:Mass [Quantitative Concept]

Phrase: "(1846daltons"

Phrase: ")"

Phrase: "corresponded"

Phrase: "closely to"

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "643-659 with the addition of a +80-dalton phosphate moiety"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   738   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   738   C0031701:phosphate [Organophosphorus Compound]
   738   C0678223:dalton [Quantitative Concept]
   738   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   738   C1883712:Addition [Functional Concept]

Phrase: "("

Phrase: "an actual addition of 84daltons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: ")"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.168: This fragment also included the serine at residue 644,a consensus PKA site. 

Phrase: "This fragment also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the serine at residue 644,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "a consensus PKA site."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205145:Site [Spatial Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
   717   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.169: Other miscut fragments from the analysis of trypsin digestions also indicated serine 644-containing fragments with the addition of an 80-dalton moiety. 

Phrase: "Other miscut"

Phrase: "fragments from the analysis of trypsin digestions also indicated serine 644-containing fragments"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   735   C0002778:Analysis [Laboratory Procedure]
   735   C0012238:digestions [Organism Function]
   735   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   735   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   735   C0332255:fragments [Functional Concept]
   735   C0332256:Containing [Functional Concept]
   735   C0486805:Fragments [Body Substance]
   735   C0936012:Analysis [Research Activity]
   735   C1444656:Indicated [Finding]
   735   C1524024:analysis [Functional Concept]
   735   C2700400:Containing [Activity]
   733   C2348822:Trypsin Digestion [Research Activity]
   702 E C1708096:Fragment [Qualitative Concept]
   702 E C2349986:Digestion [Research Activity]

Phrase: "with the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of an 80-dalton moiety."
Processing 00000000.tx.170: These miscut fragments included fragment 637-664,the mass of which measured 3162(the theoretical mass of 3085+77daltons), as well as fragment 643-675,the mass of which measured 3687(the theoretical mass of 3606+81daltons) (Fig. 2C). 

Phrase: "These miscut"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "included fragment 637-664,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0332255:fragment [Functional Concept]
   812   C0332257:included [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
   812   C3538986:INCLUDED [Gene or Genome]

Phrase: "the mass of which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "3162"

Phrase: "("

Phrase: "the theoretical mass of 3085+77daltons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "fragment 643-675,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "the mass of which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "3687"

Phrase: "("

Phrase: "the theoretical mass of 3606+81daltons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.171: No +80-dalton adducts to corresponding fragments were noted elsewhere in the spectra of either the trypsin or Lys-C proteolytic digestions. 

Phrase: "No +80-dalton adducts to corresponding fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "elsewhere in the spectra of either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "the trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "or"

Phrase: "Lys-C proteolytic digestions."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0012238:digestions [Organism Function]
   779 E C2349986:Digestion [Research Activity]
   741 E C0443277:Peptic [Functional Concept]
Processing 00000000.tx.172: EP24.15 Is Phosphorylated by PKA in Vivo in Rat PC12 and Mouse AtT-20 Cells-- To build on earlier findings (17) and confirm PKA action on rat EP24.15 in vivo, rat PC12 cells were incubated with [32P]orthophosphate and EP24.15 was immunoprecipitated. 

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Is"

Phrase: "Phosphorylated by PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in Vivo in Rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Mouse AtT-20 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "build on earlier findings"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1707059:Build [Conceptual Entity]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737   C1279919:Early [Temporal Concept]
   737 E C2825141:Finding [Finding]

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "PKA action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0441472:Action [Functional Concept]
   812   C3266814:Action [Activity]
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "on rat EP24.15 in vivo, rat PC12 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   863   C0014355:EC Cell [Cell]
   801   C0085262:PC12 Cells [Cell]
   788   C0007634:Cells [Cell]
   788   C3282337:Cells [Cell]
   755 E C1269647:Cell [Cell]
   755 E C1704653:Cell [Medical Device]
   755 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "and"

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "immunoprecipitated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.173: Analysis of the immunoprecipitate by polyacrylamide gel electrophoresis and autoradiography revealed a labeled protein band of 77-kDa present in cell extracts (Fig. 3A). 

Phrase: "Analysis of the immunoprecipitate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "by polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "autoradiography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a labeled protein band of 77-kDa present in cell extracts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0230715:A band [Cell Component]
   754   C0432611:Band cell [Cell]
   738   C0175723:Band [Medical Device]
   738   C0439645:Band [Spatial Concept]
   738   C1521913:band [Cell Component]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.174: The labeled band was extracted from the gel and subjected to phosphoamino acid analysis which revealed only serine phosphorylation (Fig. 3B), consistent with serine/threonine kinase action. 

Phrase: "The labeled band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "extracted from the gel"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C1382104:Gel [Substance]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "subjected to phosphoamino acid analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "which"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "only serine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "consistent with serine/threonine kinase action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.175: To test if EP24.15 is PKA phosphorylated in vivo, PC12 cells were subjected to a kinase activation and inhibition paradigm (Fig. 3C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "if"

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "PKA phosphorylated in vivo, PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0085262:PC12 Cells [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected to a kinase activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1879547:Activation [Activity]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "inhibition paradigm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681797:paradigm [Research Activity]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.176: Forskolin stimulation resulted in a 38% increase in 32P labeling. 

Phrase: "Forskolin stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "resulted in a 38% increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442805:Increase [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in 32P labeling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]
Processing 00000000.tx.177: Preincubation with the PKA-selective inhibitor H89 dropped 32P labeling to 58% of basal (vehicle) levels, despite the presence of forskolin. 

Phrase: "Preincubation with the PKA-selective inhibitor H89"

Phrase: "dropped"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1705648:Dropped [Activity]
   966 E C1321095:Drop [Quantitative Concept]
   966 E C2347093:Drop [Quantitative Concept]
   966 E C2348338:Drop [Quantitative Concept]

Phrase: "32P labeling to 58% of basal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "despite the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of forskolin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.178: Western blot autoradiograms showed no change in the protein expression levels secondary to the treatments (data not shown). 

Phrase: "Western blot autoradiograms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0949466:Western Blot [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no change in the protein expression levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0442739:No change [Finding]
   778   C1548568:No change [Intellectual Product]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "secondary to the treatments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0175668:Secondary to [Temporal Concept]
           Secondary
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.179: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.180: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.181: EP24.15 is phosphorylated by PKA in vivo in rat PC12 cells and mouse AtT-20 cells. 

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "phosphorylated by PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vivo in rat PC12 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "mouse AtT-20 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.182: A, autoradiograph of EP24.15 immunoprecipitated from rat PC12 cells after incubation with [32P]orthophosphate, indicated by arrow. 

Phrase: "A,"

Phrase: "autoradiograph of EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986957:Autoradiograph [Manufactured Object]

Phrase: "immunoprecipitated from rat PC12 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0085262:PC12 Cells [Cell]
           PC-12
   760   C0007634:Cells [Cell]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   760   C3282337:Cells [Cell]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "after incubation"

Phrase: "with"

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "indicated by arrow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:Arrow [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.183: B, immunoprecipitated EP24.15 (from A) was subjected to phosphoamino acid analysis as outlined under "Experimental Procedures," indicating serine phosphorylation. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "immunoprecipitated EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   766   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "("

Phrase: "from A)"

Phrase: "was"

Phrase: "subjected to phosphoamino acid analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "outlined under ""Experimental Procedures,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: """"

Phrase: "indicating"

Phrase: "serine phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.184: C, PhosphorImager quantification of [32P]orthophosphate-treated immunoprecipitated EP24.15 from PC12 cells under treatment with forskolin, or H89 and forskolin, as described under "Experimental Procedures." 

Phrase: "C,"

Phrase: "PhosphorImager quantification of [32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]orthophosphate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "immunoprecipitated EP24.15 from PC12 cells under treatment"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   756   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0085262:PC12 Cells [Cell]
           PC-12
   754   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0007634:Cells [Cell]
   738   C0039798:treatment [Functional Concept]
   738   C0087111:Treatment [Therapeutic or Preventive Procedure]
   738   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   738   C1522326:Treatment [Functional Concept]
   738   C1533734:Treatment [Therapeutic or Preventive Procedure]
   738   C1705169:Treatment [Conceptual Entity]
   738   C3282337:Cells [Cell]
   738   C3538994:TREATMENT [Research Activity]
   737   C0014355:EC Cell [Cell]
   704   C0301871:Immunoprecipitate [Immunologic Factor]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "with forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "H89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082782:h89 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.185: Determinations areS.E., n=4.*, p<0.001as compared with vehicle. 

Phrase: "Determinations areS.E.,"

Phrase: "n=4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "*,"

Phrase: "p<0.001as"

Phrase: "compared with vehicle."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   790   C1707455:Compared [Activity]
   718 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.186: **, p<0.0001as compared with vehicle. 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.0001as"

Phrase: "compared with vehicle."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   790   C1707455:Compared [Activity]
   718 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.187: D, autoradiograph of EP24.15 immunoprecipitated from mouse AtT-20 cells after incubation with [32P]orthophosphate, indicated by the arrow. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "autoradiograph of EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986957:Autoradiograph [Manufactured Object]

Phrase: "immunoprecipitated from mouse AtT-20 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C3282337:Cells [Cell]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "after incubation"

Phrase: "with"

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "indicated by the arrow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.188: E, immunoprecipitated EP24.15 (from D) was subjected to phosphoamino acid analysis as outlined under "Experimental Procedures," indicating serine phosphorylation. 

Phrase: "E,"

Phrase: "immunoprecipitated EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   766   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "("

Phrase: "from"

Phrase: "D)"

Phrase: "was"

Phrase: "subjected to phosphoamino acid analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "outlined under ""Experimental Procedures,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]

Phrase: """"

Phrase: "indicating"

Phrase: "serine phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.189: F, PhosphorImager quantification of [32P]orthophosphate-treated, immunoprecipitated EP24.15 from AtT-20 cells under treatment with forskolin, or H89 and forskolin, as described under "Experimental Procedures." 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "PhosphorImager quantification of [32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]orthophosphate-treated, immunoprecipitated EP24.15"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   822   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0029356:Orthophosphate [Inorganic Chemical]
   793   C0332293:treated [Therapeutic or Preventive Procedure]
   793   C1522326:Treated [Functional Concept]
   760   C0301871:Immunoprecipitate [Immunologic Factor]
   760 E C1292734:TREAT [Functional Concept]

Phrase: "from AtT-20 cells under treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]

Phrase: "with forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "H89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082782:h89 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.190: Determinations areS.E., n=4.***, p<0.02as compared with vehicle. 

Phrase: "Determinations areS.E.,"

Phrase: "n=4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.02as"

Phrase: "compared with vehicle."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   790   C1707455:Compared [Activity]
   718 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.191: ****, p<0.0002as compared with vehicle. 

Phrase: "*"

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.0002as"

Phrase: "compared with vehicle."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   790   C1707455:Compared [Activity]
   718 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.192: Because murine AtT-20 cells are an important cell biological model for the study of EP24.15 regulation (27, 31), we sought to determine whether PKA phosphorylation of EP24.15 was conserved across species, and specifically in this mouse model. 

Phrase: "Because"

Phrase: "murine AtT-20 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "an important cell biological model for the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026339:Model, Biological [Intellectual Product,Research Device]
   744   C3161035:Model [Intellectual Product]

Phrase: "of EP24.15 regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0851285:Regulation [Governmental or Regulatory Activity]
   799   C1327622:Regulation [Biologic Function]

Phrase: "(27,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "PKA phosphorylation of EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0031715:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "conserved across species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "specifically in this mouse model."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2986594:Mouse Model [Experimental Model of Disease]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.193: Mouse pituitary AtT-20 cells were incubated with [32P]orthophosphate and EP24.15 was immunoprecipitated (Fig. 3D). 

Phrase: "Mouse pituitary AtT-20 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0229535:Pituitary cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "and"

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.194: These cells also revealed only serine phosphorylation on EP24.15 protein (Fig. 3E). 

Phrase: "These cells also"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "only serine phosphorylation on EP24.15 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0031715:Phosphorylation [Molecular Function]

Phrase: "(Fig. 3E"

Phrase: ")."
Processing 00000000.tx.195: Again, a kinase activation and inhibition paradigm was employed (Fig. 3F) to determine if PKA is a kinase acting on EP24.15. 

Phrase: "Again,"

Phrase: "a kinase activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "inhibition paradigm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681797:paradigm [Research Activity]

Phrase: "was"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "(Fig. 3F"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "acting on EP24.15."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   714   C0079613:ACT [Therapeutic or Preventive Procedure]
Processing 00000000.tx.196: Upon stimulation of AtT-20 cells with forskolin, a 35% increase in 32P labeling was observed. 

Phrase: "Upon stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of AtT-20 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "with forskolin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "a 35% increase in 32P labeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.197: When the cells were preincubated with the PKA-selective inhibitor H89, the 32P labeling dropped to 17% of basal (vehicle). 

Phrase: "When"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with the PKA-selective inhibitor H89,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   810   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   784   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   762   C3537023:kinase inhibitor [Molecular Function]
   762   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0082782:h89 [Organic Chemical,Pharmacologic Substance]
   742   C1999216:Inhibitor [Qualitative Concept]
   726   C0428635:Protein selectivity [Laboratory Procedure]

Phrase: "the 32P labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "dropped to 17% of basal"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0205112:Basal [Spatial Concept]
   760   C1705648:Dropped [Activity]
   726 E C1321095:Drop [Quantitative Concept]
   726 E C2347093:Drop [Quantitative Concept]
   726 E C2348338:Drop [Quantitative Concept]

Phrase: "(vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")."
Processing 00000000.tx.198: In parallel, it was confirmed by scanning densitometry of the Western blot autoradiograms that there was no change in the protein expression due to the treatments (data not shown). 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "it"

Phrase: "was"

Phrase: "confirmed by scanning densitometry of the Western blot autoradiograms"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   764   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   764   C0949466:Western Blot [Laboratory Procedure]
   742   C0011321:Densitometry [Laboratory Procedure]
           densitometric scanning
   742   C0034606:Scanning [Diagnostic Procedure]
   742   C0441633:Scanning [Diagnostic Procedure]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1705493:Western [Spatial Concept]
   708 E C1456348:Confirm [Qualitative Concept]
   708 E C2826292:SCAN [Finding]

Phrase: "that there"

Phrase: "was"

Phrase: "no change in the protein expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0442739:No change [Finding]
   790   C1548568:No change [Intellectual Product]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "due to the treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.199: Molecular Cloning of Murine EP24.15 Confirms Conservation of Serine 644PKA Phosphorylation Site-- To determine whether the serine 644phosphorylation site is conserved in mouse EP24.15, and to validate the experiments in the AtT-20 model neuropeptide cell line, a mouse pituitary cDNA library was screened. 

Phrase: "Molecular Cloning of Murine EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0009015:Cloning [Research Activity]

Phrase: "Confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "Conservation of Serine 644PKA Phosphorylation Site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347858:Conservation [Qualitative Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the serine 644phosphorylation site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "conserved in mouse EP24.15,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "validate"

Phrase: "the experiments in the AtT-20 model neuropeptide cell line,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0681814:Experiments [Research Activity]
   716   C0086272:Experimental Model [Intellectual Product]
   706 E C1706386:Experiment [Conceptual Entity]

Phrase: "a mouse pituitary cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   812   C0023621:Library [Manufactured Object,Organization]
   812   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "screened."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]
Processing 00000000.tx.200: A full-length mouse EP24.15 cDNA clone was isolated and sequenced (Fig. 4). 

Phrase: "A full-length mouse EP24.15 cDNA clone"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009013:Clone [Cell]
   790   C1522642:Clone [Tissue]
   718 E C1704387:Clonal [Qualitative Concept]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.201: On the nucleic acid level, the mouse and rat coding sequences were 92.9% identical. 

Phrase: "On the nucleic acid level,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   734   C0028606:Nucleic acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat coding sequences"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   867   C0079941:Coding Sequence [Gene or Genome]
   827   C0009219:Coding [Occupational Activity]
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C0805701:Code [Intellectual Product]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "92.9% identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.202: The mouse and rat amino acid sequences shared 96.7% identity and 97.1% similarity (Fig. 5) and both species encoded a protein of 687amino acids. 

Phrase: "The mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat amino acid sequences"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   923   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0162326:Sequences [Nucleotide Sequence]
   812   C0202406:Acid [Laboratory Procedure]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "shared"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: "96.7% identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0424215:Identity [Mental Process]
   827   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "97.1% similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "both species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "a protein of 687amino acids."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.203: The structural features are as reported for the rat form of the enzyme (38), and serine 644was conserved (Fig. 5). 

Phrase: "The structural features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "are"

Phrase: "as"

Phrase: "reported for the rat form of the enzyme"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C1522492:Form [Functional Concept]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "(38"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "serine 644was"

Phrase: "conserved"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.204: View larger version (90K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(90K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334335:90K [Gene or Genome]
  1000   C1705384:90K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.205: 4.  

Phrase: "4."
Processing 00000000.tx.206: Nucleotide and deduced amino acid sequences of mouse pituitary endopeptidase 3.4.24.15cDNA (GenBankTM accession no. AF314187) EBI. 

Phrase: "Nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "deduced amino acid sequences"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   923   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0162326:Sequences [Nucleotide Sequence]
   812   C0202406:Acid [Laboratory Procedure]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "of mouse pituitary endopeptidase 3.4.24.15cDNA"

Phrase: "(GenBankTM accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. AF314187"

Phrase: ")"

Phrase: "EBI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420599:EBI [Gene or Genome]
Processing 00000000.tx.207: Nucelotides are numbered on the right column. 

Phrase: "Nucelotides"

Phrase: "are"

Phrase: "numbered on the right column."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205090:Right [Spatial Concept]
   760   C0449788:numbered [Quantitative Concept]
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]
   726 E C0237753:*Number [Quantitative Concept]
Processing 00000000.tx.208: Amino acid numbering commences from the start methionine on the right in bold above its codon. 

Phrase: "Amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "commences from the start methionine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0439659:Start [Temporal Concept]
   760   C3274784:Commence [Activity]

Phrase: "on the right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "in bold"

Phrase: "above its codon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009221:Codon [Nucleotide Sequence]
  1000   C1095825:Codon [Plant]
Processing 00000000.tx.209: An asterisk indicates the stop codon (TGA) of the open reading frame. 

Phrase: "An asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "indicates"

Phrase: "the stop codon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242611:Stop Codon [Nucleotide Sequence]
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "(TGA) of the open reading frame."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2699751:TGA [Gene or Genome]
Processing 00000000.tx.210: The polyadenylation signal is underlined. 

Phrase: "The polyadenylation signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "underlined."
Processing 00000000.tx.211: View larger version (55K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(55K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.212: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.213: Amino acid sequence alignment of rat and mouse EP24.15. 

Phrase: "Amino acid sequence alignment of rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   753   C1706765:Alignment [Quantitative Concept]

Phrase: "and"

Phrase: "mouse EP24.15."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]
Processing 00000000.tx.214: Rat EP24.15 (accession number P24155) (Ref. 35) and mouse EP24.15 (accession number AF314187) with putative phosphorylation sites indicated: PKA sites are bold, PKC sites are underlined, and casein kinase II sites have curved number underlines. 

Phrase: "Rat EP24.15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0034693:Rat, NOS [Mammal]
   799   C0034721:Rat [Mammal]

Phrase: "(accession number P24155"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: "(Ref. 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "mouse EP24.15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]

Phrase: "(accession number AF314187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1510755:Accession Number [Intellectual Product]

Phrase: ")"

Phrase: "with putative phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   867   C1519063:Phosphorylation Site [Amino Acid Sequence]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C0205145:Sites [Spatial Concept]
   827   C1158886:Phosphorylation [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ":"

Phrase: "PKA sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "are"

Phrase: "bold, PKC sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "underlined"

Phrase: ","

Phrase: "and"

Phrase: "casein kinase II sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
   756   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "curved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curved [Spatial Concept]

Phrase: "number underlines."
Processing 00000000.tx.215: The conserved PKA phosphorylation site, serine 644,is indicated by number sign. r, rat; 

Phrase: "The conserved PKA phosphorylation site,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   827   C1519063:Phosphorylation Site [Amino Acid Sequence]
   799   C0031715:Phosphorylation [Molecular Function]
   799   C0205145:Site [Spatial Concept]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]

Phrase: "serine 644,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "indicated by number sign. r,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205090:R- [Spatial Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0311392:Sign [Finding]
   760   C0449788:Number [Quantitative Concept]
   760   C0684010:R. [Professional or Occupational Group]
   760   C1444656:Indicated [Finding]
   760   C1547188:Sign [Idea or Concept]
   760   C2603358:R' [Clinical Attribute]

Phrase: "rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: ";"
Processing 00000000.tx.216: m, mouse; 

Phrase: "m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: ";"
Processing 00000000.tx.217: :, residue conserved.  

Phrase: ":"

Phrase: ","

Phrase: "residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "conserved."
Processing 00000000.tx.218: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Whereas there are many possible mechanisms by which peptidase activity may be regulated, the presence of numerous putative phosphorylation sites on EP24.15 led us to examine whether phosphorylation plays a role in its modulation. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C1514811:Reference [Idea or Concept]
   758   C1706462:Reference [Conceptual Entity]

Phrase: "Whereas"

Phrase: "there"

Phrase: "are"

Phrase: "many possible mechanisms by which peptidase activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "the presence of numerous putative phosphorylation sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "on EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in its modulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.219: Of the kinases studied, only PKA elicited significant phosphorylation (Fig. 1B). 

Phrase: "Of the kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: ","

Phrase: "only PKA elicited significant phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.220: The effects of the in vitro PKA phosphorylation of EP24.15 on enzyme kinetics with different substrates was assessed. 

Phrase: "The effects of the in vitro PKA phosphorylation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "on enzyme kinetics"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1516893:Enzyme Kinetics [Occupation or Discipline]
   861   C0022702:Kinetics [Natural Phenomenon or Process]
   861   C0220865:kinetics [Functional Concept]
   861   C2825046:Kinetics [Occupation or Discipline]

Phrase: "with different substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "was"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.221: The 46,44,and 40% decline in the kcat/Km observed for QF7 and QFS, and GnRH1-9, respectively, suggested a possible mechanism of down-regulation of EP24.15 activity upon phosphorylation. 

Phrase: "The 46,"

Phrase: "44,"

Phrase: "and"

Phrase: "40% decline in the kcat/Km"

Phrase: "observed for QF7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "QFS,"

Phrase: "and"

Phrase: "GnRH1-9,"

Phrase: "respectively,"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a possible mechanism of down-regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "of EP24.15 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "upon phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.222: These kinetic changes are the same magnitude elicited by phosphorylation as observed in other systems where there was further amplification through signal transduction. 

Phrase: "These kinetic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "the same magnitude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449286:magnitude [Quantitative Concept]
   861   C1704240:Magnitude [Quantitative Concept]

Phrase: "elicited by phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0449265:Elicited by [Qualitative Concept]
           elicited
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "as"

Phrase: "observed in other systems where there"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1441672:Observed [Functional Concept]
   719   C0449913:System [Functional Concept]
   719   C1553451:System [Manufactured Object]
   719   C1704459:System [Medical Device]

Phrase: "was"

Phrase: "further amplification through signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.223: A phosphorylation-induced 50-60% decrease in activity has been reported for caspase-9 (15), which has significant downstream consequences in the apoptotic cascade. 

Phrase: "A phosphorylation-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "50-60% decrease in activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported for caspase-9"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "has"

Phrase: "significant downstream consequences in the apoptotic cascade."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0686907:consequences [Functional Concept]
Processing 00000000.tx.224: There are compelling physiological data (2-4) establishing EP24.15 as the primary GnRH processing enzyme in vivo. 

Phrase: "There"

Phrase: "are"

Phrase: "compelling physiological data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "(2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "establishing EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0443211:establishing [Qualitative Concept]

Phrase: "as the primary GnRH processing enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.225: For example, upon intracerebroventricular administration of a specific EP24.15 inhibitor, the half-life of GnRH increased 8-fold (2). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "upon intracerebroventricular administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of a specific EP24.15 inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1999216:Inhibitor [Qualitative Concept]

Phrase: "the half-life of GnRH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0018517:Half-Life [Temporal Concept]
   760   C0376558:Life [Idea or Concept]
   760   C2825407:Half [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.226: Additionally, peripheral infusion of the EP24.15 inhibitor augmented the GnRH-dependent luteinizing hormone surge in rats (4). 

Phrase: "Additionally,"

Phrase: "peripheral infusion of the EP24.15 inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0574032:Infusion [Therapeutic or Preventive Procedure]
   739   C1827465:Infusion [Functional Concept]

Phrase: "augmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]

Phrase: "the GnRH-dependent luteinizing hormone surge in rats"

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.227: GnRH secretion from the hypothalamus in a pulsatile fashion is critical for the proper release of luteinizing hormone and follicle stimulating hormone from the pituitary, and the resultant control of mammalian reproduction (42). 

Phrase: "GnRH secretion from the hypothalamus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "in a pulsatile fashion"

Phrase: "is"

Phrase: "critical for the proper release of luteinizing hormone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1511545:Critical [Qualitative Concept]

Phrase: "and"

Phrase: "follicle stimulating hormone from the pituitary,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   864   C0733758:Pituitary follicle stimulating hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Follicle Stimulating Hormone
   783   C0032015:Pituitary hormone [Amino Acid, Peptide, or Protein,Hormone]
   753   C0018120:Follicle [Body Part, Organ, or Organ Component]
   753   C0019932:Hormone [Hormone]
   753   C1571705:Follicle [Body Part, Organ, or Organ Component]
   753   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the resultant control of mammalian reproduction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   756   C0017263:genetic control [Genetic Function]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   742 E C0700589:Birth Control [Therapeutic or Preventive Procedure]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.228: As such, understanding the kinetic aspects of GnRH degradation at the release site by EP24.15 is fundamentally important in understanding GnRH pulse waveform regulation. 

Phrase: "As"

Phrase: "such,"

Phrase: "understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the kinetic aspects of GnRH degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0243125:degradation aspects [Functional Concept]
   719   C1547011:Aspect [Quantitative Concept]
   719   C1879746:Aspect [Qualitative Concept]

Phrase: "at the release site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0030685:Release [Health Care Activity]
   861   C0205145:Site [Spatial Concept]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   861   C2825164:Site [Spatial Concept]

Phrase: "by EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "fundamentally important in understanding GnRH pulse waveform regulation."
Processing 00000000.tx.229: In this study, there was a 7-fold increase in Km and kcat (and correspondingly, Vmax) observed with GnRH upon EP24.15 phosphorylation. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "there"

Phrase: "was"

Phrase: "a 7-fold increase in Km"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "kcat ("

Phrase: "and"

Phrase: "correspondingly,"

Phrase: "Vmax)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710637:Vmax [Phenomenon or Process]

Phrase: "observed with GnRH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C1441672:Observed [Functional Concept]

Phrase: "upon EP24.15 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.230: These changes imply that the affinity of GnRH binding was reduced upon phosphorylation, but once bound, the substrate appears to be turned over more rapidly. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "imply"

Phrase: "that"

Phrase: "the affinity of GnRH binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "reduced upon phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0392756:Reduced [Qualitative Concept]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "but"

Phrase: "once"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: ","

Phrase: "the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "over more rapidly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205136:Over [Spatial Concept]
   827   C1637379:Rapidly [Qualitative Concept]
Processing 00000000.tx.231: It is possible that the phosphorylated enzyme has the versatility to expediently handle large increases in GnRH concentration (during the large increase in amplitude, concomitant with GnRH pulsatile release), without becoming rapidly saturated at these substrate concentrations. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the phosphorylated enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "the versatility to expediently handle large increases"

Phrase: "in GnRH concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "during the large increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in amplitude,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "concomitant with GnRH pulsatile release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0521115:Concomitant [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "without"

Phrase: "becoming"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "saturated at these substrate concentrations."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0522534:Saturated [Phenomenon or Process]
   760   C1705188:SATURATED [Quantitative Concept]
   760   C1710236:Substrate [Manufactured Object]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.232: The insulin peptide concentration in secretory vesicles has been measured to be approximately 40mM just prior to release (43). 

Phrase: "The insulin peptide concentration in secretory vesicles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "approximately 40mM just prior to release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0450402:40mm [Quantitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.233: In another study (44), the concentration of neuropeptide achieved at the site of release at the synapse has been postulated to approach ~10 mM in synaptic vesicles. 

Phrase: "In another study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "the concentration of neuropeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "achieved at the site of release"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C2945843:Site of [Qualitative Concept]
   753   C0030685:Release [Health Care Activity]
   753   C0205145:Site [Spatial Concept]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2825164:Site [Spatial Concept]

Phrase: "at the synapse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039062:Synapse [Body Space or Junction]

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "~10 mM in synaptic vesicles."
Processing 00000000.tx.234: Therefore, it is quite plausible that peptide concentrations in the synapse at the point of vesicular release can approach the in vitro Km range of ~100 M described here and by others (45), as well as 1mM upon phosphorylation. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "quite plausible"

Phrase: "that peptide concentrations in the synapse"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "at the point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "of vesicular release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "the in vitro Km range of ~100 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0441923:M+ [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "and by others"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   790   C1955473:Others [Finding]

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "1mM upon phosphorylation."
Processing 00000000.tx.235: Overall, these findings suggest that phosphorylation can have a significant impact on EP24.15 activity by preventing its saturation at the time of pulsatile release, and hence, GnRH hydrolysis. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "can"

Phrase: "have"

Phrase: "a significant impact on EP24.15 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1825598:IMPACT [Gene or Genome]

Phrase: "by preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "its saturation at the time of pulsatile release,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0522534:Saturation [Phenomenon or Process]

Phrase: "and"

Phrase: "hence,"

Phrase: "GnRH hydrolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.236: If EP24.15 exists in the hypophysial portal blood both in a phosphorylated and non-phosphorylated state, the effective substrate concentration range of this enzyme would be substantially broadened. 

Phrase: "If"

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "exists in the hypophysial portal blood"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0032005:Hypophyseal [Body Part, Organ, or Organ Component]
   753   C0205054:Portal [Body Location or Region]
   753   C0229664:Blood [Body Substance]
   753   C2987476:Exist [Conceptual Entity]

Phrase: "both in a phosphorylated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "non-phosphorylated state,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "the effective substrate concentration range of this enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "would"

Phrase: "be"

Phrase: "substantially"

Phrase: "broadened."
Processing 00000000.tx.237: We next sought to understand the nature of the biophysical changes conferred by phosphorylation of EP24.15. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the nature of the biophysical changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "conferred by phosphorylation of EP24.15."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.238: None of the kinetic changes outlined (Table II) would appear to be the result of limited substrate accessibility to the active site, given the nearly identical Ki determinations with phosphorylated and non-phosphorylated EP24.15 for the active site-directed inhibitor cFP-AAF-pAB. 

Phrase: "None of the kinetic changes"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0022702:kinetic [Natural Phenomenon or Process]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]
   704 E C0026597:Motion [Natural Phenomenon or Process]
   704 E C0687704:Motions [Functional Concept]

Phrase: "outlined"

Phrase: "(Table II"

Phrase: ")"

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the result of limited substrate accessibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "to the active site,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the nearly identical Ki determinations with phosphorylated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0680730:determinations [Governmental or Regulatory Activity]
   714 E C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "non-phosphorylated EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1518422:Non [Functional Concept]

Phrase: "for the active site-directed inhibitor cFP-AAF-pAB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   845   C0083564:cFP-AAF-pAB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.239: We further hypothesized that the major alterations in kinetic parameters observed with GnRH as compared with GnRH1-9, were perhaps due to a direct interaction of the phosphate group of the enzyme with the carboxyl-terminal amide of the substrate peptide (this glycine-amide being absent in GnRH1-9), where there might be repulsion and conformational alterations with respect to the carboxyl moiety in GnRH1-9. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the major alterations in kinetic parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "observed with GnRH as"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C1441672:Observed [Functional Concept]

Phrase: "compared with GnRH1-9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "were"

Phrase: "perhaps due to a direct interaction of the phosphate group of the enzyme"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   750   C0678226:Due to [Functional Concept]
           due
   749   C0441835:Group A [Classification]
   749   C3537101:Enzyme Interaction [Molecular Function]
   735   C0014442:Enzyme [Enzyme,Organic Chemical]
   735   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   735   C0031701:phosphate [Organophosphorus Compound]
   735   C0439851:Direct [Qualitative Concept]
   735   C0441833:Group [Idea or Concept]
   735   C0687744:group [Population Group]
   735   C1257890:Group [Population Group]
   735   C1552516:Group [Health Care Related Organization]
   735   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   735   C1704675:Interaction [Functional Concept]
   735   C1705428:Group [Conceptual Entity]
   735   C1705429:Group [Population Group]
   735   C1947931:Direct [Qualitative Concept]
   735   C3146286:Due [Idea or Concept]

Phrase: "with the carboxyl-terminal amide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002482:Amide [Organic Chemical]

Phrase: "of the substrate peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "this glycine-amide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061596:glycinamide [Amino Acid, Peptide, or Protein]
   861   C0002482:Amide [Organic Chemical]
   861   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0522461:Glycine [Plant]

Phrase: "being"

Phrase: "absent in GnRH1-9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: ")"

Phrase: ","

Phrase: "where there"

Phrase: "might"

Phrase: "be"

Phrase: "repulsion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683283:repulsion [Mental Process]

Phrase: "and"

Phrase: "conformational alterations with respect to the carboxyl moiety"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1515926:Alteration [Idea or Concept]

Phrase: "in GnRH1-9."
Processing 00000000.tx.240: In this context, we examined the kinetics of both phosphorylated and non-phosphorylated EP24.15 with bradykinin-amide and bradykinin in a manner identical to that for GnRH and GnRH1-9, respectively. 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the kinetics of both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022702:Kinetics [Natural Phenomenon or Process]
   770   C0220865:kinetics [Functional Concept]
   770   C2825046:Kinetics [Occupation or Discipline]

Phrase: "phosphorylated"

Phrase: "and"

Phrase: "non-phosphorylated EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1518422:Non [Functional Concept]

Phrase: "with bradykinin-amide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002482:Amide [Organic Chemical]

Phrase: "and"

Phrase: "bradykinin in a manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   770   C1537501:bradykinin [Gene or Genome]

Phrase: "identical to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "for GnRH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "and"

Phrase: "GnRH1-9,"

Phrase: "respectively."
Processing 00000000.tx.241: The Km of EP24.15 for bradykinin increased upon phosphorylation, while for bradykinin-amide it decreased, not in agreement with the relative changes seen with GnRH and GnRH1-9. 

Phrase: "The Km of EP24.15"

Phrase: "for bradykinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "increased upon phosphorylation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1158886:Phosphorylation [Molecular Function]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "while for bradykinin-amide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002482:Amide [Organic Chemical]
   770   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   770   C0750519:while [Idea or Concept]
   770   C1537501:bradykinin [Gene or Genome]

Phrase: "it"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "not in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1518422:Not [Functional Concept]

Phrase: "with the relative changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "seen with GnRH"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "and"

Phrase: "GnRH1-9."
Processing 00000000.tx.242: This would suggest that the major changes observed in the kinetic parameters for GnRH upon EP24.15 phosphorylation are not likely a charge-induced phenomenon. 

Phrase: "This"

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the major changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "observed in the kinetic parameters"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0022702:kinetic [Natural Phenomenon or Process]
   760   C0449381:Parameters [Finding]
   760   C1441672:Observed [Functional Concept]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]
   704 E C0026597:Motion [Natural Phenomenon or Process]
   704 E C0687704:Motions [Functional Concept]

Phrase: "for GnRH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "upon EP24.15 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "are"

Phrase: "not likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "a charge-induced phenomenon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882365:Phenomenon [Phenomenon or Process]
Processing 00000000.tx.243: There may exist other, as yet unknown, binding mechanisms which differentiate between the two substrates (GnRH and GnRH1-9). 

Phrase: "There"

Phrase: "may"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "other,"

Phrase: "as yet unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "which"

Phrase: "differentiate between the two substrates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C0205615:differentiate [Qualitative Concept]
   726   C1710236:Substrate [Manufactured Object]

Phrase: "(GnRH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "and"

Phrase: "GnRH1-9"

Phrase: ")."
Processing 00000000.tx.244: More importantly, it indicates that the phosphorylation of EP24.15 alters its neuropeptide kinetic profile and substrate specificity. 

Phrase: "More importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "it"

Phrase: "indicates"

Phrase: "that"

Phrase: "the phosphorylation of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "its neuropeptide kinetic profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "substrate specificity."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificity [Quantitative Concept]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.245: Systematic site-directed mutagenesis of all putative serine PKA phosphorylation sites to alanine, indicated serine 644to be the primary site of in vitro phosphorylation (Fig. 2A). 

Phrase: "Systematic site-directed mutagenesis of all putative serine PKA phosphorylation sites"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   766   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   749   C2945843:Site of [Qualitative Concept]
   735   C0079866:Mutagenesis [Molecular Function]
   735   C0205145:Site [Spatial Concept]
   735   C1515974:Site [Body Location or Region]
   735   C2825164:Site [Spatial Concept]
   735   C3146302:Mutagenesis [Laboratory Procedure]
   702   C0439851:Direct [Qualitative Concept]
   702   C1947931:Direct [Qualitative Concept]

Phrase: "to alanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "indicated serine 644to"

Phrase: "be"

Phrase: "the primary site of in vitro phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0449695:Primary site [Spatial Concept]
   778   C2945843:Site of [Qualitative Concept]
   774   C1519063:Phosphorylation Site [Amino Acid Sequence]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.246: To confirm the serine 644phosphorylation site, cyanogen bromide cleavage was utilized since there are few overlapping putative phosphorylated peptides by mass. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the serine 644phosphorylation site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "cyanogen bromide cleavage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0010511:Cyanogen Bromide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0006222:Bromide [Inorganic Chemical]
   827   C0010813:cleavage [Cell Function]
   827   C0056658:cyanogen [Hazardous or Poisonous Substance,Inorganic Chemical]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "utilized"

Phrase: "since"

Phrase: "there"

Phrase: "are"

Phrase: "few"

Phrase: "overlapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:Overlapping [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlapping [Conceptual Entity]

Phrase: "putative phosphorylated peptides by mass."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1519061:Phosphorylated Peptide [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.247: A labeled 2000-dalton fragment correlated uniquely to the cyanogen bromide fragment 640-657(mass 1987), containing serine 644(Fig. 

Phrase: "A labeled 2000-dalton fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "uniquely to the cyanogen bromide fragment 640-657"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010511:Cyanogen Bromide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   744   C0006222:Bromide [Inorganic Chemical]
   744   C0056658:cyanogen [Hazardous or Poisonous Substance,Inorganic Chemical]
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "(mass 1987"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "serine 644"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.248: 2B). 

Phrase: "2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.249: We continued further mapping of the phosphorylated protein with trypsin and Lys-C utilizing MALDI-TOF mass analyses. 

Phrase: "We"

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "further mapping of the phosphorylated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]

Phrase: "with trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "Lys-C utilizing MALDI-TOF mass analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0002778:Analysis [Laboratory Procedure]
   762   C0936012:Analysis [Research Activity]
   762   C1524024:analysis [Functional Concept]
Processing 00000000.tx.250: As anticipated, trypsin digestion yielded a complex spectra containing miscuts due to the phosphorylation blocking enzyme access to the adjacent Lys/Arg residues, but clearly indicated peptides with +80-dalton adducts (phosphoryl groups) not seen in the non-phosphorylated enzyme (Fig. 2C). 

Phrase: "As"

Phrase: "anticipated"

Phrase: ","

Phrase: "trypsin digestion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2348822:Trypsin Digestion [Research Activity]
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]

Phrase: "yielded"

Phrase: "a complex spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "miscuts due to the phosphorylation blocking enzyme access"

Phrase: "to the adjacent Lys/Arg residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "but"

Phrase: "clearly indicated peptides with +80-dalton adducts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(phosphoryl groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in the non-phosphorylated enzyme"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0205397:Seen [Qualitative Concept]
   753   C1518422:Non [Functional Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.251: The most complete cleavage with trypsin yielded the 643-659 fragment. 

Phrase: "The most complete cleavage with trypsin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "yielded"

Phrase: "the 643-659 fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.252: This fragment contained an internal arginine (647), situated amino to a proline residue, a combination of residues which is known to cleave very inefficiently with trypsin. 

Phrase: "This fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "an internal arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(647"

Phrase: ")"

Phrase: ","

Phrase: "situated"

Phrase: "amino to a proline residue,"

Phrase: "a combination of residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "very inefficiently with trypsin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0442824:Very [Qualitative Concept]
Processing 00000000.tx.253: Furthermore, limited proteolysis with endoproteinase Lys-C yielded spectra with a full cut fragment (), consistent with serine 644phosphorylation (Fig. 2C). 

Phrase: "Furthermore,"

Phrase: "limited proteolysis with endoproteinase Lys-C yielded spectra"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597304:Proteolysis [Molecular Function]

Phrase: "with a full cut fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "consistent with serine 644phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.254: Serine 644was conserved between rat and mouse, a finding paralleled by the in vivo data demonstrating that PKA is contributing to EP24.15 phosphorylation in both rat and mouse cell lines. 

Phrase: "Serine 644was"

Phrase: "conserved between rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "paralleled by the in vivo data"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]
   719   C2348042:Parallel [Qualitative Concept]
   719   C2826345:PARALLEL [Research Activity]

Phrase: "demonstrating"

Phrase: "that PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "contributing to EP24.15 phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1880177:Contributing [Activity]

Phrase: "in both rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "mouse cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   983   C1513528:Mouse Cell Line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.255: In the human EP24.15 sequence, 6of 7putative PKA sites are conserved, but not the serine 644consensus site. 

Phrase: "In the human EP24.15 sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   795   C0004793:Sequence [Nucleotide Sequence]
   795   C0162326:Sequence [Nucleotide Sequence]
   795   C0162327:Sequence [Nucleotide Sequence]
   795   C1519249:Sequence [Functional Concept]
   724 E C1548958:Sequential [Idea or Concept]
   724 E C1705294:Sequential [Qualitative Concept]

Phrase: "6of 7putative PKA sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0205145:Sites [Spatial Concept]
   766 E C1515974:Site [Body Location or Region]
   766 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "conserved"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the serine 644consensus site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.256: Nonetheless, when human M17 neuroblastoma cells were subjected a similar PKA kinase activation/inhibition scheme, EP24.15 likewise was phosphorylated by PKA (data not shown). 

Phrase: "Nonetheless,"

Phrase: "when"

Phrase: "human M17 neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "a similar PKA kinase activation/inhibition scheme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1519193:Scheme [Intellectual Product]

Phrase: "EP24.15 likewise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "phosphorylated by PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.257: Importantly, in a fashion similar to rat and mouse (Fig. 3), the PKA phosphorylation of EP24.15 still occurs in vivo in human cells. 

Phrase: "Importantly,"

Phrase: "in a fashion"

Phrase: "similar to rat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "the PKA phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   812   C0031715:Phosphorylation [Molecular Function]
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "of EP24.15 still"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in vivo in human cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.258: Homology modeling studies of EP24.15 based on the bacterial enzymes, thermolysin, and neutral protease (previously solved to atomic resolution by x-ray diffraction), indicate the presence of a 4-helix bundle structural motif in the carboxyl-terminal 80-95 residues.2 This motif has been previously modeled by homology to the related metalloenzymes enkephalinase and angiotensin converting enzyme (46). 

Phrase: "Homology modeling studies of EP24.15"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "based on the bacterial enzymes,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0521009:Bacterial [Qualitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "thermolysin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039815:Thermolysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "neutral protease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1882074:Neutral [Qualitative Concept]
   861   C1947941:Protease [Enzyme]
   861   C2825492:Neutral [Phenomenon or Process]

Phrase: "(previously"

Phrase: "solved to atomic resolution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514893:Resolution [Idea or Concept]
   770   C1706463:Resolution [Quantitative Concept]
   770   C2699488:Resolution [Conceptual Entity]

Phrase: "by x-ray diffraction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0043301:X-Ray Diffraction [Laboratory Procedure]
   901   C0034571:X-ray [Functional Concept]
   901   C0043299:X-ray, NOS [Diagnostic Procedure]
   901   C0043309:X-ray [Natural Phenomenon or Process]
   901   C1306645:X-ray [Diagnostic Procedure]
   901   C1962945:X-ray [Diagnostic Procedure]
   827   C0086894:ray [Fish]
   827   C0851346:ray [Natural Phenomenon or Process]
   827   C2314876:ray [Fish]

Phrase: ")"

Phrase: ","

Phrase: "indicate"

Phrase: "the presence of a 4-helix bundle structural motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the carboxyl-terminal 80-95 residues.2"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0205088:Terminal [Temporal Concept]
   799   C0596260:Carboxyl [Organic Chemical]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]

Phrase: "This motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "modeled by homology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1334043:Homology [Gene or Genome]
   790   C2697616:Homology [Qualitative Concept]
   756   C3161035:Model [Intellectual Product]

Phrase: "to the related metalloenzymes enkephalinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025250:Enkephalinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1366499:ENKEPHALINASE [Gene or Genome]

Phrase: "and"

Phrase: "angiotensin converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.259: In this model, serine 644would reside near the carboxyl end of the second helix in a 4-helix bundle, a structural motif present in many proteins (reviewed in Ref. 47). 

Phrase: "In this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "serine 644would"

Phrase: "reside near the carboxyl end of the second helix"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0018882:Helix [Eukaryote]
   742   C0205436:Second [Quantitative Concept]
   742   C0229304:Helix [Body Part, Organ, or Organ Component]
   742   C0444930:End [Spatial Concept]
   742   C0457385:Second [Temporal Concept]
   742   C0565930:/second [Quantitative Concept]
   742   C0596260:Carboxyl [Organic Chemical]
   742   C1561503:second [Idea or Concept]
   742   C1704821:Helix [Spatial Concept]
   742   C1705190:Second [Qualitative Concept]
   742   C1705682:Helix [Anatomical Structure]
   742   C2746065:End [Temporal Concept]
   742   C2982691:Reside [Activity]

Phrase: "in a 4-helix bundle,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0018882:Helix [Eukaryote]
   827   C0229304:Helix [Body Part, Organ, or Organ Component]
   827   C1704821:Helix [Spatial Concept]
   827   C1705682:Helix [Anatomical Structure]

Phrase: "a structural motif present in many proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: "reviewed in Ref. 47"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.260: The closest distance approximation of serine 644to the active site zinc is approximately 17, seemingly too far for a direct steric effect in the active site. 

Phrase: "The closest distance approximation of serine 644to"

Phrase: "the active site zinc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C2348288:Zinc [Element, Ion, or Isotope]
   734   C0205681:Active Site [Functional Concept]

Phrase: "is"

Phrase: "approximately 17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332232:Approximately [Qualitative Concept]

Phrase: "seemingly too far for a direct steric effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205108:far [Spatial Concept]
   744   C0439851:Direct [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C1947931:Direct [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in the active site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.261: This interpretation is consistent with the unchanged EP24.15 inhibitor (cFP-AAF-pAB) Ki data upon phosphorylation, although it is possible a longer range conformational change in the protein is modulated through this structural motif. 

Phrase: "This interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "is"

Phrase: "consistent with the unchanged EP24.15 inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(cFP-AAF-pAB) Ki data upon phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "although"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "a longer range conformational change in the protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0301641:Conformational change [Molecular Function]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "modulated through this structural motif."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443264:Modulated [Spatial Concept]
   760   C0678594:Structural [Spatial Concept]
   760   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.262: As our initial studies characterizing the phosphorylation and inhibition of EP24.15 activity had been performed in vitro with recombinant enzyme, therefore it was important to determine if phosphorylation of EP24.15 occurs in mammalian cells. 

Phrase: "As our initial studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0205265:Initial [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   861   C1279901:Initial [Qualitative Concept]
   861   C1555582:Initial [Idea or Concept]
   861   C1705685:INITIAL [Functional Concept]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "characterizing"

Phrase: "the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "inhibition of EP24.15 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "had"

Phrase: "been"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in vitro with recombinant enzyme,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "therefore"

Phrase: "it"

Phrase: "was"

Phrase: "important to"

Phrase: "determine"

Phrase: "if"

Phrase: "phosphorylation of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "occurs in mammalian cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.263: Interestingly, an earlier study in rat pheochromocytoma (PC12) cells treated with cAMP analogues showed a decrease in the soluble specific activity of EP24.15 without a decrease in the amount of EP24.15 protein (17). 

Phrase: "Interestingly,"

Phrase: "an earlier study in rat pheochromocytoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "(PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with cAMP analogues"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737   C0243071:Analogue [Chemical Viewed Structurally]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a decrease in the soluble specific activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "without a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "in the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of EP24.15 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.264: We extend this observation by specifically demonstrating decreases in EP24.15 enzyme activity by PKA phosphorylation in vitro, and by demonstration of the PKA phosphorylation of EP24.15 in PC12 cells. 

Phrase: "We"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "this observation by specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "demonstrating"

Phrase: "decreases in EP24.15 enzyme activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0547047:decreases [Quantitative Concept]
   708 E C0392756:Decrease [Qualitative Concept]

Phrase: "by PKA phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   812   C0031715:Phosphorylation [Molecular Function]
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and by demonstration of the PKA phosphorylation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1515981:And [Idea or Concept]

Phrase: "of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.265: We further explored whether the PKA phosphorylation of EP24.15 is conserved in a commonly used mouse neuroendocrine cell model. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "explored"

Phrase: "whether"

Phrase: "the PKA phosphorylation of EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   738   C0031715:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "conserved in a commonly used mouse neuroendocrine cell model."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C1518275:Neuroendocrine cell [Cell]
   762   C2986594:Mouse Model [Experimental Model of Disease]
   742   C0007634:Cell [Cell]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0027912:Neuroendocrine [Body System]
   742   C1269647:Cell [Cell]
   742   C1273517:used [Finding]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3161035:Model [Intellectual Product]
Processing 00000000.tx.266: Utilizing the AtT-20 mouse pituitary cell line, our studies indicated that EP24.15 can be phosphorylated by PKA. 

Phrase: "Utilizing"

Phrase: "the AtT-20 mouse pituitary cell line,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   867   C1513528:Mouse Cell Line [Cell]
   827   C0007600:Cell Line [Cell]
   827   C0229535:Pituitary cell [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:Line [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1550648:Line [Substance]
   799   C1552960:Line [Quantitative Concept]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated by PKA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.267: As was the case in the PC12 cells, EP24.15 phosphorylation was enhanced by forskolin treatment, and inhibited by the PKA-selective inhibitor H89 (48) concomitant with forskolin treatment. 

Phrase: "As"

Phrase: "was"

Phrase: "the case in the PC12 cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: "EP24.15 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "enhanced by forskolin treatment,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0917964:Forskolin [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C2349975:Enhanced [Activity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "inhibited by the PKA-selective inhibitor H89"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   810   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   784   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   762   C3537023:kinase inhibitor [Molecular Function]
   762   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0082782:h89 [Organic Chemical,Pharmacologic Substance]
   742   C0311403:Inhibited [Qualitative Concept]
   742   C1999216:Inhibitor [Qualitative Concept]
   726   C0428635:Protein selectivity [Laboratory Procedure]

Phrase: "(48"

Phrase: ")"

Phrase: "concomitant with forskolin treatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0521115:Concomitant [Temporal Concept]
Processing 00000000.tx.268: The complete cDNA cloning of mouse EP24.15 (Fig. 4) and alignment with the rat sequence (Fig. 5) indicated the perfect conservation of the PKA phosphorylation site, serine 644. 

Phrase: "The complete cDNA cloning of mouse EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0009015:Cloning [Research Activity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "alignment with the rat sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0080143:Sequence Alignment [Molecular Biology Research Technique]
   760   C1706765:Alignment [Quantitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the perfect conservation of the PKA phosphorylation site,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2347858:Conservation [Qualitative Concept]

Phrase: "serine 644."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.269: It is also possible that phosphorylation may regulate EP24.15 function by subcellular targeting and/or expression at the plasma membrane (27), the nucleus (4, 49), or other cellular locations, either directly or via protein-protein interactions. 

Phrase: "It"

Phrase: "is"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "may"

Phrase: "regulate"

Phrase: "EP24.15 function by subcellular targeting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]

Phrase: "and/or"

Phrase: "expression at the plasma membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(4,"

Phrase: "49"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "other cellular locations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0450429:locations [Spatial Concept]
   827 E C1515974:Location [Body Location or Region]

Phrase: "either directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947931:Directly [Qualitative Concept]

Phrase: "or via protein-protein interactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   828   C0872079:Protein-Protein Interaction [Molecular Function]
           interactions protein
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.270: For example, enkephalinase (EC 3.4.24.11), a related enzyme, can be phosphorylated by casein kinase II, and subsequently co-associates with a tyrosine-phosphoprotein complex in Nalm 6(lymphoblastic leukemia) cells, suggesting a role for this peptidase in signal transduction pathways (50). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "enkephalinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Enkephalinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:ENKEPHALINASE [Gene or Genome]

Phrase: "(EC 3.4.24.11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "a related enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated by casein kinase II,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "subsequently"

Phrase: "co-associates with a tyrosine-phosphoprotein complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0031689:Phosphoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   714   C0750490:Associate [Idea or Concept]
   714   C1706221:Associate [Professional or Occupational Group]

Phrase: "in Nalm 6"

Phrase: "(lymphoblastic leukemia"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0023448:Lymphoblastic leukemia [Neoplastic Process]
  1000   C0023449:Lymphoblastic leukaemia [Neoplastic Process]
  1000   C1961102:Lymphoblastic Leukemia [Neoplastic Process]
   861   C0023418:Leukaemia [Neoplastic Process]
   861   C0229613:lymphoblastic [Cell]
   789 E C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role for this peptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0086982:Signal Transduction Pathways [Molecular Function]
   913   C0037080:Signal Pathways [Molecular Function]
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.271: Previously, a faster migrating form of EP24.15 was found to be present on the plasma membrane of AtT-20 cells (27). 

Phrase: "Previously,"

Phrase: "a faster migrating form of EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present on the plasma membrane of AtT-20 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.272: By performing labeling studies of AtT-20 cells with [35S]Met/Cys (detecting all forms) performed in parallel with [33P]orthophosphate labeling (providing higher resolution than 32P), this faster migrating form of the enzyme was not a phosphorylated form of EP24.15 (data not shown). 

Phrase: "By performing labeling studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "of AtT-20 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "with"

Phrase: "[35S"

Phrase: "]Met/Cys ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0442726:detect [Finding]

Phrase: "all forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in parallel with"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0150312:In [Quantitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C2348042:Parallel [Qualitative Concept]
   790   C2826345:PARALLEL [Research Activity]

Phrase: "[33P"

Phrase: "]orthophosphate labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(providing higher resolution than 32P"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1719039:High resolution [Laboratory Procedure]
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C2699488:Resolution [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "this faster migrating form of the enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a phosphorylated form of EP24.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.273: Interestingly, serine 644resides within a potential 14-3-3-binding protein consensus site (reviewed in Ref. 51). 

Phrase: "Interestingly,"

Phrase: "serine 644resides"

Phrase: "within a potential 14-3-3-binding protein consensus site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   836   C0005456:Binding Site [Receptor]
   836   C0682969:Binding Site [Amino Acid Sequence]
   793   C0205145:Site [Spatial Concept]
   793   C1515974:Site [Body Location or Region]
   793   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "reviewed in Ref. 51"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.274: 14-3-3proteins have been demonstrated to interact with various signaling proteins through phosphoserine motifs, one of which is RXpSXXXP found in several proteins (52), exactly matching the motif at serine 644of EP24.15. 

Phrase: "14-3-3proteins"

Phrase: "have"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with various signaling proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0037083:Signaling [Cell Function]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "through phosphoserine motifs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1519064:Phosphoserine Motif [Amino Acid Sequence]
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "RXpSXXXP"

Phrase: "found in several proteins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "(52"

Phrase: ")"

Phrase: ","

Phrase: "exactly"

Phrase: "matching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:MATCHING [Research Activity]
  1000   C1708943:Matching [Qualitative Concept]

Phrase: "the motif at serine 644of EP24.15."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.275: Thus, phosphorylation may actually represent a modification which induces multidimensional modulations of EP24.15: both spatio-temporal as well as kinetic. 

Phrase: "Thus,"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "may"

Phrase: "actually"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "which"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "multidimensional modulations of EP24.15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0443264:Modulation [Spatial Concept]

Phrase: ":"

Phrase: "both spatio-temporal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442043:Temporal [Spatial Concept]
   861   C2362314:Temporal [Temporal Concept]

Phrase: "as well as"

Phrase: "kinetic."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0022702:kinetic [Natural Phenomenon or Process]
   944 E C0026597:Motion [Natural Phenomenon or Process]
   944 E C0687704:Motions [Functional Concept]
   928 E C0022699:Kineses [Individual Behavior]
Processing 00000000.tx.276: Now that the site of phosphorylation has been identified, future studies can address the role of phosphorylation and its influence on trafficking using appropriate mutant EP24.15 expression vectors. 

Phrase: "Now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "that"

Phrase: "the site of phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2945843:Site of [Qualitative Concept]
   819   C1519063:Phosphorylation Site [Amino Acid Sequence]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "future studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "can"

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the role of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "its influence on"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "appropriate mutant EP24.15 expression vectors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   807   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   791   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   791   C0442335:Vectors [Spatial Concept]
   758 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.277: In summary, the present report demonstrates phosphorylation of EP24.15 by PKA on serine 644.

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the present report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "demonstrates"

Phrase: "phosphorylation of EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "by PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on serine 644."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.278: Importantly, EP24.15 is phosphorylated by PKA in both mouse and rat species which both share this conserved phosphorylation site. 

Phrase: "Importantly,"

Phrase: "EP24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "phosphorylated by PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in both mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "which both"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "this conserved phosphorylation site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1519063:Phosphorylation Site [Amino Acid Sequence]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1158886:Phosphorylation [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.279: This results in an alteration of neuropeptide hydrolyzing activity indicating phosphorylation as a possible physiological regulator of EP24.15 activity.  

Phrase: "This results in an alteration of neuropeptide hydrolyzing activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "indicating"

Phrase: "phosphorylation as a possible physiological regulator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "of EP24.15 activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.280: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.281: Mary Ann Gawinowicz of the Howard Hughes Medical Institute/Columbia University Protein Facility for valuable advice and expertise in mass spectrometry. 

Phrase: "Mary Ann Gawinowicz of the Howard Hughes Medical Institute/Columbia University Protein Facility"

Phrase: "for valuable advice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150600:Advice [Health Care Activity]

Phrase: "and"

Phrase: "expertise in mass spectrometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0870520:expertise [Qualitative Concept]
Processing 00000000.tx.282: We are grateful for helpful discussions with Dr. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful for helpful discussions"

Phrase: "with Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.283: Ciaran Fagan, Dublin City University, and Dr. 

Phrase: "Ciaran Fagan,"

Phrase: "Dublin City University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.284: Julie Kelly and Prof. 

Phrase: "Julie Kelly"

Phrase: "and"

Phrase: "Prof."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599518:Prof. [Professional or Occupational Group]
Processing 00000000.tx.285: Keith Tipton, Trinity College, Dublin. 

Phrase: "Keith Tipton,"

Phrase: "Trinity College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "Dublin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454777:Dublin [Geographic Area]
Processing 00000000.tx.286: Many thanks to Dr. 

Phrase: "Many"

Phrase: "thanks to Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C2986676:THANK [Gene or Genome]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.287: Paul Schober (PepTech, Dee Why, Australia) for providing GnRH1-9 and GnRH1-5, Dr. 

Phrase: "Paul Schober"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0944325:Schober [Clinical Attribute]

Phrase: "(PepTech,"

Phrase: "Dee Why,"

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")"

Phrase: "for providing GnRH1-9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1999230:Provide [Activity]

Phrase: "and"

Phrase: "GnRH1-5,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.288: Luiz Juliano (Universidade Federal de Sao Paulo) for QF7 substrate, and Dr. 

Phrase: "Luiz Juliano"

Phrase: "(Universidade Federal de Sao Paulo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1862323:SAO [Gene or Genome]

Phrase: ")"

Phrase: "for QF7 substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.289: Robert Krauss (Mount Sinai School of Medicine, New York) for the kind gift of the PKC-overexpressing cell lines.  

Phrase: "Robert Krauss"

Phrase: "(Mount Sinai School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ")"

Phrase: "for the kind gift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0423899:Gifted [Finding]

Phrase: "of the PKC-overexpressing cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.290: FOOTNOTES * This work was supported by Molecular and Cellular Endocrinology Training Grant T32-DK07645 (to J.W.T.and M.C.L.), NIDA Training Grant 2T32-DA7135-16 (to P.M.C.), grants from the National Health and Medical Research Council of Australia (to A.I.S.and C.N.S.), National Institutes of Health Grant P30-HD28822 (to J.A.M.), Fundao de Amparo  Pesquisa do Estado de So Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnolgico (to E.S.F.), National Institutes of Health Grants NS37421 (to J.L.R.and M.J.G.) and NS39892 (to M.J.G.).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Molecular"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1521721:Supported [Conceptual Entity]
   790   C1521991:Molecular [Qualitative Concept]
   756 E C0183683:Support [Medical Device]
   718 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Endocrinology Training Grant T32-DK07645"

Phrase: "("

Phrase: "to J.W.T."

Phrase: "and"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "NIDA Training Grant 2T32-DA7135-16"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   827   C0555633:Training grant [Intellectual Product]
   799   C0018173:Grant [Quantitative Concept]
   799   C0040607:Training [Educational Activity]
   799   C0068218:NIDA [Organic Chemical]
   799   C0220931:Training [Educational Activity]
   799   C1513899:NIDA [Health Care Related Organization]
   799   C1548284:Grant [Idea or Concept]
   799   C2673163:training [Qualitative Concept]
   766 E C0336809:Train [Manufactured Object]
   766 E C1552514:Train [Manufactured Object]
   727 E C0009647:Conditioned [Mental Process]
   727 E C0012634:condition [Disease or Syndrome]
   727 E C0348080:Condition [Qualitative Concept]
   727 E C1705253:Condition [Conceptual Entity]

Phrase: "("

Phrase: "to P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "C."

Phrase: ")"

Phrase: ","

Phrase: "grants from the National Health and Medical Research Council of Australia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   754   C0260206:Research Grants [Research Activity]
   738   C0018173:Grants [Quantitative Concept]
   704 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to A.I.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "C.N.S."

Phrase: ")"

Phrase: ","

Phrase: "National Institutes of Health Grant P30-HD28822"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "("

Phrase: "to J.A.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "Fundao de Amparo  Pesquisa"

Phrase: "do"

Phrase: "Estado de So Paulo"

Phrase: "and"

Phrase: "Conselho Nacional de Desenvolvimento Cientifico e Tecnolgico"

Phrase: "("

Phrase: "to E.S.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "National Institutes of Health Grants NS37421"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "("

Phrase: "to J.L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "M."

Phrase: "J.G.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "NS39892"

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.291: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.292: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.293: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.294: The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF314187. 

Phrase: "The nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: "reported in this paper"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0030351:Paper [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1547566:Paper [Idea or Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "submitted to the GenBankTM/EMBL Data Bank"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0242356:Data Bank [Intellectual Product]
   748   C0442598:Bank [Manufactured Object]
   748   C0872261:Bank [Manufactured Object]
   748   C1511726:Data [Idea or Concept]
   748   C1515023:Submitted [Functional Concept]
   748   C3245479:data [Medical Device]

Phrase: "with accession number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1510755:Accession Number [Intellectual Product]
           Accession
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C1706078:Accession [Activity]

Phrase: "("

Phrase: "s)"

Phrase: "AF314187."
Processing 00000000.tx.295: Current address: Dept. of Histology and Embryology, Biomedical Science Institute, University of Sao Paulo, Sao Paulo, 05508-900,Brazil. 

Phrase: "Current address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Histology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019638:Histology [Biomedical Occupation or Discipline]
  1000   C0205462:histology [Functional Concept]
  1000   C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "Embryology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0013942:Embryology [Biomedical Occupation or Discipline]
  1000   C0013943:embryology [Functional Concept]
   928 E C0013935:Embryologic [Embryonic Structure]

Phrase: "Biomedical Science Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "University of Sao Paulo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041740:University [Manufactured Object,Organization]
   812   C1862323:SAO [Gene or Genome]

Phrase: "Sao Paulo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1862323:SAO [Gene or Genome]

Phrase: "05508-900,"

Phrase: "Brazil."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006137:Brazil [Geographic Area]
Processing 00000000.tx.296: ** To whom correspondence should be addressed: Structural Neurobiology and Proteomics Laboratory, Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, Box 1065,1425Madison Ave., New York, NY 10029-6574.Tel.: 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Structural Neurobiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027817:Neurobiology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Proteomics Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Fishberg Research Center for Neurobiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0683939:research center [Manufactured Object,Organization]
   760   C0205099:Center [Spatial Concept]

Phrase: "Mount Sinai School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Box 1065,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "1425Madison Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY 10029-6574.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0796520:TEL [Gene or Genome]
   812   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.297: 212-659-5973; 

Phrase: "212-659-5973"

Phrase: ";"
Processing 00000000.tx.298: Fax: 212-996-9785; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "212-996-9785"

Phrase: ";"
Processing 00000000.tx.299: E-mail: glux@msvax.mssm.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "glux@msvax.mssm.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.300: Published, JBC Papers in Press, August 31,2000,DOI 10.1074/jbc.M001843200 2 M. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "August 31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M001843200 2 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.301: J.

Phrase: "J."
Processing 00000000.tx.302: Glucksman, M.Cascio, and J.L.

Phrase: "Glucksman,"

Phrase: "M."

Phrase: "Cascio,"

Phrase: "and"

Phrase: "J.L."
Processing 00000000.tx.303: Roberts, manuscript in preparation.  

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "manuscript in preparation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.304: ABBREVIATIONS The abbreviations used are: EP24.15, endopeptidase EC3.4.24.15; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "EP24.15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "endopeptidase EC3.4.24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   911   C0116036:endopeptidase 24.15 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.305: cFP-AAF-pAB, N-[1-(RS)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate; 

Phrase: "cFP-AAF-pAB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0083564:cFP-AAF-pAB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "N-[1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(RS)-carboxy-3-phenylpropyl"

Phrase: "]-Ala-Ala-Phe-p-aminobenzoate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0000473:Aminobenzoate [Organic Chemical,Pharmacologic Substance,Vitamin]
   804   C0552314:Aminobenzoate [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.306: CKII, casein kinase II; 

Phrase: "CKII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707154:CKII [Gene or Genome]

Phrase: "casein kinase II"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.307: Dnp, dinitrophenyl; 

Phrase: "Dnp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0045511:DNP [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C0678100:DNP [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.308: GnRH, gonadotropin-releasing hormone; 

Phrase: "GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "gonadotropin-releasing hormone"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
  1000   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   827   C1283071:Releasing [Functional Concept]
   827   C3536870:Gonadotropin [Pharmacologic Substance]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.309: H89, N-[2((p-bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide-HCl; 

Phrase: "H89,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082782:h89 [Organic Chemical,Pharmacologic Substance]

Phrase: "N-[2("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(p-bromocinnamyl"

Phrase: ")"

Phrase: "amino)ethyl"

Phrase: "]-5-isoquinolinesulfonamide-HCl"

Phrase: ";"
Processing 00000000.tx.310: Lys-C, endoproteinase Lys-C; 

Phrase: "Lys-C,"

Phrase: "endoproteinase Lys-C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0164055:endoproteinase Lys-C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.311: MALDI-TOF, matrix-assisted laser desorption-ionization-time of flight; 

Phrase: "MALDI-TOF,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1518101:MALDI-TOF [Research Activity]
   861   C0039685:TOF [Congenital Abnormality]
   861   C1825291:TOF [Gene or Genome]
   861   C2348791:TOF [Quantitative Concept]

Phrase: "matrix-assisted laser desorption-ionization-time of flight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C2348791:Time-of-Flight [Quantitative Concept]
   744   C0040223:Time [Temporal Concept]
   744   C3541383:Time [Temporal Concept]
   703   C0282597:matrix assisted laser desorption ionization [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.312: MCA, 7-methoxycoumarin-4-acetyl; 

Phrase: "MCA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "7-methoxycoumarin-4-acetyl"

Phrase: ";"
Processing 00000000.tx.313: NT, neurotensin; 

Phrase: "NT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "neurotensin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027930:Neurotensin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1417869:NEUROTENSIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.314: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.315: PKA, cAMP-dependent protein kinase; 

Phrase: "PKA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cAMP-dependent protein kinase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0010531:cAMP-Dependent Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: ";"
Processing 00000000.tx.316: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.317: QF7, orthoaminobenzoyl-Gly-Gly-Phe-Leu-Arg-Arg-Val-N-(2,4-dinitrophenyl)-ethylenediamine; 

Phrase: "QF7,"

Phrase: "orthoaminobenzoyl-Gly-Gly-Phe-Leu-Arg-Arg-Val-N-(2,4-dinitrophenyl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   787   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   705   C0061714:(Gly)4 [Amino Acid, Peptide, or Protein]

Phrase: ")-"

Phrase: "ethylenediamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015091:Ethylenediamine [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.318: QFS, 7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-Pro-D-Lys-(2,4-dinitrophenyl).  

Phrase: "QFS,"

Phrase: "7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0072136:Pro-Leu-Gly [Amino Acid, Peptide, or Protein]
   829   C0072142:Pro-Gly [Amino Acid, Peptide, or Protein]
   818   C0125601:Leu-Gly [Amino Acid, Peptide, or Protein]
   795   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Pro-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2987124:PRO [Intellectual Product]

Phrase: "D-"

Phrase: "Lys-(2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "4-dinitrophenyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678100:dinitrophenyl [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.319: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.320: Hardie, D. 

Phrase: "Hardie,"

Phrase: "D."
Processing 00000000.tx.321: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.322: (1992) Biochemical Messengers: Hormones, Neurotransmitters, and Growth Factors , Chapman and Hall, London 2. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochemical Messengers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0815028:biochemical messengers [Biologically Active Substance]
   861   C0169911:messengers [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0335218:messengers [Professional or Occupational Group]

Phrase: ":"

Phrase: "Hormones,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "Neurotransmitters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "Growth Factors ,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "Chapman"

Phrase: "and"

Phrase: "Hall,"

Phrase: "London 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023973:London [Geographic Area]
Processing 00000000.tx.323: Lasdun, A., Reznik, S., Molineaux, C. 

Phrase: "Lasdun,"

Phrase: "A.,"

Phrase: "Reznik,"

Phrase: "S."

Phrase: ","

Phrase: "Molineaux,"

Phrase: "C."
Processing 00000000.tx.324: J., and Orlowski, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.325: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.326: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.327: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.328: Ther. 

Phrase: "Ther."
Processing 00000000.tx.329: 251, 439-437[Abstract] 3. 

Phrase: "251,"

Phrase: "439-437"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.330: Lasdun, A., and Orlowski, M. 

Phrase: "Lasdun,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.332: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.333: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.334: Ther. 

Phrase: "Ther."
Processing 00000000.tx.335: 253, 1265-1271[Abstract] 4. 

Phrase: "253,"

Phrase: "1265-1271"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 4."
Processing 00000000.tx.336: Wu, T. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.337: J., Pierotti, A. 

Phrase: "J.,"

Phrase: "Pierotti,"

Phrase: "A."
Processing 00000000.tx.338: R., Jakubowski, M., Sheward, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jakubowski,"

Phrase: "M."

Phrase: ","

Phrase: "Sheward,"

Phrase: "W."
Processing 00000000.tx.339: J., Glucksman, M. 

Phrase: "J.,"

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.340: J., Smith, A. 

Phrase: "J.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.341: I., King, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "King,"

Phrase: "J."
Processing 00000000.tx.342: C., Fink, G., and Roberts, J. 

Phrase: "C., Fink,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.343: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.344: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.345: Neuroendocrinol. 

Phrase: "Neuroendocrinol."
Processing 00000000.tx.346: 9, 813-822[Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "9,"

Phrase: "813-822"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.347: Vincent, B., Jiracek, J., Noble, F., Loog, M., Roques, B., Dive, V., Vincent, J. 

Phrase: "Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jiracek,"

Phrase: "J.,"

Phrase: "Noble,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Loog,"

Phrase: "M."

Phrase: ","

Phrase: "Roques,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dive,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0012823:dive [Daily or Recreational Activity]
  1000   C0325913:dive [Bird]
   966 E C1412762:Diva [Gene or Genome]
   966 E C2700407:DIVA [Gene or Genome]

Phrase: "V.,"

Phrase: "Vincent,"

Phrase: "J."
Processing 00000000.tx.348: P., and Checler, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.349: (1997) Eur. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.350: J.

Phrase: "J."
Processing 00000000.tx.351: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.352: 334, 49-53[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "334,"

Phrase: "49-53"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.353: Orlowski, M., Michaud, C., and Chu, T. 

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "Michaud,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.354: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.355: (1983) Eur. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.356: J.

Phrase: "J."
Processing 00000000.tx.357: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.358: 135, 80-88 7. 

Phrase: "135,"

Phrase: "80-88 7."
Processing 00000000.tx.359: Dahms, P., and Mentlein, R. 

Phrase: "Dahms,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Mentlein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.360: (1992) Eur. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.361: J.

Phrase: "J."
Processing 00000000.tx.362: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.363: 208, 145-154[Abstract] 8. 

Phrase: "208,"

Phrase: "145-154"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 8."
Processing 00000000.tx.364: Montiel, J.-L., Cornille, F., Roques, B. 

Phrase: "Montiel,"

Phrase: "J.-L., Cornille,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Roques,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.365: P., and Noble, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Noble,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.366: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.367: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.368: 68, 354-361[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "354-361"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.369: Chu, T. 

Phrase: "Chu,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.370: G., and Orlowski, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: (1985) Endocrinology 116, 1418-1425[Abstract] 10. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Endocrinology 116,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "1418-1425"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 10."
Processing 00000000.tx.372: Kest, B., Orlowski, M., and Bodnar, R. 

Phrase: "Kest,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bodnar,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.373: J. 

Phrase: "J."
Processing 00000000.tx.374: (1992) Psychopharmacology 106, 408-416[Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Psychopharmacology 106,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033929:Psychopharmacology [Biomedical Occupation or Discipline]

Phrase: "408-416"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.375: Yamin, R., Malgeri, E., Sloane, J. 

Phrase: "Yamin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Malgeri,"

Phrase: "E.,"

Phrase: "Sloane,"

Phrase: "J."
Processing 00000000.tx.376: A., McGraw, W. 

Phrase: "A.,"

Phrase: "McGraw,"

Phrase: "W."
Processing 00000000.tx.377: T., and Abraham, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.378: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.379: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.380: Biol. 

Phrase: "Biol."
Processing 00000000.tx.381: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.382: 274, 18777-18784[Abstract/Free FullText] 12. 

Phrase: "274,"

Phrase: "18777-18784"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.383: Shrimpton, C. 

Phrase: "Shrimpton,"

Phrase: "C."
Processing 00000000.tx.384: N., Glucksman, M. 

Phrase: "N., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: J., Lew, R. 

Phrase: "J.,"

Phrase: "Lew,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.386: A., Tullai, J. 

Phrase: "A.,"

Phrase: "Tullai,"

Phrase: "J."
Processing 00000000.tx.387: W., Margulies, E. 

Phrase: "W., Margulies,"

Phrase: "E."
Processing 00000000.tx.388: H., Roberts, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.389: L., and Smith, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.390: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.391: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.392: Biol. 

Phrase: "Biol."
Processing 00000000.tx.393: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.394: 272, 17395-17399[Abstract/Free FullText] 13. 

Phrase: "272,"

Phrase: "17395-17399"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.395: Nestler, E. 

Phrase: "Nestler,"

Phrase: "E."
Processing 00000000.tx.396: J., and Greengard, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.397: (1983) Nature 305, 583-588[Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Nature 305,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "583-588"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.398: Mason, G. 

Phrase: "Mason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.399: G.F., Kendil, K. 

Phrase: "G.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kendil,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.400: B., and Rivett, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Rivett,"

Phrase: "A."
Processing 00000000.tx.401: J. 

Phrase: "J."
Processing 00000000.tx.402: (1996) Eur. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.403: J.

Phrase: "J."
Processing 00000000.tx.404: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.405: 238, 453-462[Abstract] 15. 

Phrase: "238,"

Phrase: "453-462"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 15."
Processing 00000000.tx.406: Cardone, M. 

Phrase: "Cardone,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.407: H., Roy, N., Stennicke, H. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roy,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Stennicke,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.408: R., Salvesen, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Salvesen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.409: S., Franke, T. 

Phrase: "S."

Phrase: ","

Phrase: "Franke,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.410: F., Stanbridge, E., Frisch, S., and Reed, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Stanbridge,"

Phrase: "E.,"

Phrase: "Frisch,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Reed,"

Phrase: "J."
Processing 00000000.tx.411: C. 

Phrase: "C."
Processing 00000000.tx.412: (1998) Science 282, 1318-1321[Abstract/Free FullText] 16. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Science 282,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1318-1321"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.413: Martins, L. 

Phrase: "Martins,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.414: M., Kottke, T. 

Phrase: "M."

Phrase: ","

Phrase: "Kottke,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.415: J., Kaufmann, S. 

Phrase: "J.,"

Phrase: "Kaufmann,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.416: H., and Earnshaw, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Earnshaw,"

Phrase: "W."
Processing 00000000.tx.417: C. 

Phrase: "C."
Processing 00000000.tx.418: (1998) Blood 92, 3042-3049[Abstract/Free FullText] 17. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Blood 92,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "3042-3049"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.419: Ferro, E. 

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.420: S., Tambourgy, D. 

Phrase: "S."

Phrase: ","

Phrase: "Tambourgy,"

Phrase: "D."
Processing 00000000.tx.421: V., Abreu, P. 

Phrase: "V., Abreu,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.422: A., Camargo, A. 

Phrase: "A.,"

Phrase: "Camargo,"

Phrase: "A."
Processing 00000000.tx.423: C., Raw, I., and Ho, P. 

Phrase: "C., Raw, I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1547546:C-I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.424: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.425: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.426: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.427: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.428: 57, 311-320[Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "57,"

Phrase: "311-320"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.429: Sevetson, B. 

Phrase: "Sevetson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.430: R., Kong, X., and Lawrence, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kong,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Lawrence,"

Phrase: "J."
Processing 00000000.tx.431: C., Jr. 

Phrase: "C., Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.432: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.433: Natl. 

Phrase: "Natl."
Processing 00000000.tx.434: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.435: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.436: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.437: 90, 10305-10309[Abstract] 19. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "10305-10309"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 19."
Processing 00000000.tx.438: Graves, L. 

Phrase: "Graves,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.439: M., Bornfeldt, K. 

Phrase: "M."

Phrase: ","

Phrase: "Bornfeldt,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.440: E., Raines, E. 

Phrase: "E.,"

Phrase: "Raines,"

Phrase: "E."
Processing 00000000.tx.441: W., Potts, B. 

Phrase: "W., Potts,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.442: C., MacDonald, S. 

Phrase: "C., MacDonald,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.443: G., Ross, R., and Krebs, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Krebs,"

Phrase: "E."
Processing 00000000.tx.444: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.445: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.446: Natl. 

Phrase: "Natl."
Processing 00000000.tx.447: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.448: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.449: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.450: 90, 10300-10304[Abstract] 20. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "10300-10304"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 20."
Processing 00000000.tx.451: Pearson, R. 

Phrase: "Pearson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.452: B., and Kemp, B. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Kemp,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.453: E. 

Phrase: "E."
Processing 00000000.tx.454: (1991) Methods Enzymol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.455: 200, 62-81[Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "200,"

Phrase: "62-81"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.456: Glucksman, M. 

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.457: J., and Roberts, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.458: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.459: (1995) Methods Neurosci. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Neurosci."
Processing 00000000.tx.460: 23, 296-316 22. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "296-316 22."
Processing 00000000.tx.461: Cummins, P. 

Phrase: "Cummins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.462: M., Pabon, A., Margulies, E. 

Phrase: "M."

Phrase: ","

Phrase: "Pabon,"

Phrase: "A.,"

Phrase: "Margulies,"

Phrase: "E."
Processing 00000000.tx.463: H., and Glucksman, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.464: J. 

Phrase: "J."
Processing 00000000.tx.465: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.466: Biol. 

Phrase: "Biol."
Processing 00000000.tx.467: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.468: 274, 16003-16009[Abstract/Free FullText] 23. 

Phrase: "274,"

Phrase: "16003-16009"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.469: Laemmli, U. 

Phrase: "Laemmli,"

Phrase: "U."
Processing 00000000.tx.470: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.471: (1970) Nature 227, 680-685[Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "(1970"

Phrase: ")"

Phrase: "Nature 227,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "680-685"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.472: Cacace, A. 

Phrase: "Cacace,"

Phrase: "A."
Processing 00000000.tx.473: M., Guadagno, S. 

Phrase: "M."

Phrase: ","

Phrase: "Guadagno,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.474: N., Krauss, R. 

Phrase: "N., Krauss,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.475: S., Fabbro, D., and Weinstein, I. 

Phrase: "S."

Phrase: ","

Phrase: "Fabbro,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Weinstein,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.476: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.477: (1993) Oncogene 8, 2095-2104[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Oncogene 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "2095-2104"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.478: Krauss, R. 

Phrase: "Krauss,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.479: S., Guadangno, S. 

Phrase: "S."

Phrase: ","

Phrase: "Guadangno,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.480: N., and Weinstein, I. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Weinstein,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.481: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.482: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.483: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.484: Biol. 

Phrase: "Biol."
Processing 00000000.tx.485: 1, 3117-3129 26. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3117-3129 26."
Processing 00000000.tx.486: Van der Geer, P., Luo, K., Sefton, B. 

Phrase: "Van der Geer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sefton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.487: M., and Hunter, T. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.488: (1993) in Protein Phosphorylation, A Practical Approach (Hardie, D. G., ed) , pp. 

Phrase: "(1993"

Phrase: ")"

Phrase: "in Protein Phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   861   C0031715:Phosphorylation [Molecular Function]

Phrase: "A Practical Approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "(Hardie,"

Phrase: "D. G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439417:d g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.489: 32-33, Oxford University Press, New York 27. 

Phrase: "32-33,"

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "New York 27."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]
Processing 00000000.tx.490: Crack, P. 

Phrase: "Crack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706353:Crack [Finding]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.491: J., Wu, T. 

Phrase: "J.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.492: J., Cummins, P. 

Phrase: "J.,"

Phrase: "Cummins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.493: M., Ferro, E. 

Phrase: "M."

Phrase: ","

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.494: S., Tullai, J. 

Phrase: "S."

Phrase: ","

Phrase: "Tullai,"

Phrase: "J."
Processing 00000000.tx.495: W., Glucksman, M. 

Phrase: "W., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.496: J., and Roberts, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.497: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.498: (1999) Brain Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.499: 835, 113-124[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "835,"

Phrase: "113-124"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.500: Juliano, L., Chagas, J. 

Phrase: "Juliano,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chagas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0697125:chaga [Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.501: R., Hirata, I. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hirata,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.502: Y., Carmona, E., Sucupira, M., Oliveira, E. 

Phrase: "Y.,"

Phrase: "Carmona,"

Phrase: "E.,"

Phrase: "Sucupira,"

Phrase: "M."

Phrase: ","

Phrase: "Oliveira,"

Phrase: "E."
Processing 00000000.tx.503: S., Oliveira, E. 

Phrase: "S."

Phrase: ","

Phrase: "Oliveira,"

Phrase: "E."
Processing 00000000.tx.504: B., and Camargo, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Camargo,"

Phrase: "E."
Processing 00000000.tx.505: C.M. 

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.506: (1990) Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.507: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.508: 173, 647-652 29. 

Phrase: "173,"

Phrase: "647-652 29."
Processing 00000000.tx.509: Lineweaver, H., and Burk, D. 

Phrase: "Lineweaver,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Burk,"

Phrase: "D."
Processing 00000000.tx.510: (1934) J. 

Phrase: "(1934"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.511: Am. 

Phrase: "Am."
Processing 00000000.tx.512: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.513: Soc. 

Phrase: "Soc."
Processing 00000000.tx.514: 56, 658-666 30. 

Phrase: "56,"

Phrase: "658-666 30."
Processing 00000000.tx.515: Dixon, M. 

Phrase: "Dixon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.516: (1959) Biochem. 

Phrase: "(1959"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.517: J. 

Phrase: "J."
Processing 00000000.tx.518: 55, 170-171 31. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "170-171 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450355:31 [Intellectual Product]
Processing 00000000.tx.519: Ferro, E. 

Phrase: "Ferro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454671:Ferro [Geographic Area]

Phrase: "E."
Processing 00000000.tx.520: S., Tullai, J. 

Phrase: "S."

Phrase: ","

Phrase: "Tullai,"

Phrase: "J."
Processing 00000000.tx.521: W., Glucksman, M. 

Phrase: "W., Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.522: J., and Roberts, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.523: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.524: (1999) DNA Cell Biol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "DNA Cell Biol."
Processing 00000000.tx.525: 18, 781-789[CrossRef][Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "18,"

Phrase: "781-789"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.526: Niedbalski, J. 

Phrase: "Niedbalski,"

Phrase: "J."
Processing 00000000.tx.527: S., and Ringer, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ringer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]

Phrase: "D."
Processing 00000000.tx.528: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.529: (1986) Anal. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.530: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.531: 158, 138-145[Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "158,"

Phrase: "138-145"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.532: Neufeld, E., Goren, H. 

Phrase: "Neufeld,"

Phrase: "E.,"

Phrase: "Goren,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.533: J., and Boland, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Boland,"

Phrase: "D."
Processing 00000000.tx.534: (1989) Anal. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.535: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.536: 177, 138-143[Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "177,"

Phrase: "138-143"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.537: Smith, B. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.538: J. 

Phrase: "J."
Processing 00000000.tx.539: (1994) in Methods in Molecular Biology: Basic Protein and Peptide Protocols (Walker, J. M., ed) , pp. 

Phrase: "(1994"

Phrase: ")"

Phrase: "in Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "in Molecular Biology"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: ":"

Phrase: "Basic Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Peptide Protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "(Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.540: 297-309, Humana Press, Inc., Totowa, NJ 35. 

Phrase: "297-309,"

Phrase: "Humana Press,"

Phrase: "Inc.,"

Phrase: "Totowa,"

Phrase: "NJ 35."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]
Processing 00000000.tx.541: Asara, J. 

Phrase: "Asara,"

Phrase: "J."
Processing 00000000.tx.542: M., and Allison, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Allison,"

Phrase: "J."
Processing 00000000.tx.543: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.544: Am. 

Phrase: "Am."
Processing 00000000.tx.545: Soc. 

Phrase: "Soc."
Processing 00000000.tx.546: Mass Spectrom. 

Phrase: "Mass Spectrom."
Processing 00000000.tx.547: 10, 35-44[CrossRef][Medline] [OrderarticleviaInfotrieve] 36. 

Phrase: "10,"

Phrase: "35-44"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 36."
Processing 00000000.tx.548: Wilkins, M. 

Phrase: "Wilkins,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.549: R., Lindskog, I., Gasteiger, E., Bairoch, A., Sanchez, J.-C., Hochstrasser, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lindskog,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gasteiger,"

Phrase: "E.,"

Phrase: "Bairoch,"

Phrase: "A.,"

Phrase: "Sanchez,"

Phrase: "J.-C., Hochstrasser,"

Phrase: "D."
Processing 00000000.tx.550: F., and Appel, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Appel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.551: D. 

Phrase: "D."
Processing 00000000.tx.552: (1997) Electrophoresis 18, 403-408[Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Electrophoresis 18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "403-408"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.553: Wilkins, M. 

Phrase: "Wilkins,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.554: R., Gasteiger, E., Bairoch, A., Sanchez, J.-C., Williams, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gasteiger,"

Phrase: "E.,"

Phrase: "Bairoch,"

Phrase: "A.,"

Phrase: "Sanchez,"

Phrase: "J.-C., Williams,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.555: L., Appel, R. 

Phrase: "L., Appel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.556: D., and Hochstrasser, D. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Hochstrasser,"

Phrase: "D."
Processing 00000000.tx.557: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.558: (1998) in 2-D Proteome Analysis Protocols (Link, A. J., ed) , pp. 

Phrase: "(1998"

Phrase: ")"

Phrase: "in 2-D Proteome Analysis Protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0442711:Protocols [Intellectual Product]
   771 E C1507394:Protocol [Intellectual Product]
   771 E C1522729:Protocol [Intellectual Product]
   771 E C2348563:Protocol [Intellectual Product]

Phrase: "(Link,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "A. J.,"

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.559: 531-552, Humana Press, Totowa, NJ 38. 

Phrase: "531-552,"

Phrase: "Humana Press,"

Phrase: "Totowa,"

Phrase: "NJ 38."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]
Processing 00000000.tx.560: Pierotti, A., Dong, K., Glucksman, M. 

Phrase: "Pierotti,"

Phrase: "A.,"

Phrase: "Dong,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.561: J., Orlowski, M., and Roberts, J. 

Phrase: "J.,"

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.562: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.563: (1990) Biochemistry 29, 10323-10329[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochemistry 29,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10323-10329"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.564: Higgins, D. 

Phrase: "Higgins,"

Phrase: "D."
Processing 00000000.tx.565: G., Thompson, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thompson,"

Phrase: "J."
Processing 00000000.tx.566: D., and Gibson, T. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Gibson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.567: J. 

Phrase: "J."
Processing 00000000.tx.568: (1996) Methods Enzymol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.569: 266, 383-402[Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "266,"

Phrase: "383-402"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.570: Orlowski, M., Michaud, C., and Molineaux, C. 

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "Michaud,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Molineaux,"

Phrase: "C."
Processing 00000000.tx.571: J. 

Phrase: "J."
Processing 00000000.tx.572: (1988) Biochemistry 27, 597-602[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Biochemistry 27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "597-602"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.573: Garvey, E. 

Phrase: "Garvey,"

Phrase: "E."
Processing 00000000.tx.574: P., and Matthews, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Matthews,"

Phrase: "C."
Processing 00000000.tx.575: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.576: (1989) Biochemistry 28, 2083-2093[Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Biochemistry 28,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "2083-2093"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.577: Levine, J. 

Phrase: "Levine,"

Phrase: "J."
Processing 00000000.tx.578: E. 

Phrase: "E."
Processing 00000000.tx.579: (1999) in Encyclopedia of Reproduction (Knobil, E. , and Neill, J. D., eds), Vol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "in Encyclopedia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014095:encyclopedia [Intellectual Product]

Phrase: "of Reproduction"
Meta Candidates (Total=16; Excluded=15; Pruned=0; Remaining=1)
  1000   C0035150:Reproduction [Organism Function]
   944 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   944 E C0314603:Genetic [Functional Concept]
   944 E C0559522:Genital [Body System]
   944 E C1546649:Genital [Intellectual Product]
   944 E C1550642:Genital [Body Substance]
   916 E C0005615:Birth [Organism Function]
   916 E C0079946:origin [Classification]
   916 E C0439659:Origin [Temporal Concept]
   916 E C1550512:origin [Intellectual Product]
   916 E C1550722:birth [Idea or Concept]
   916 E C3245487:birth [Intellectual Product]
   900 E C0454729:Natal [Geographic Area]
   893 E C0205313:Original [Idea or Concept]
   893 E C2347409:Original [Occupational Activity]
   880 E C0598240:originality [Mental Process]

Phrase: "(Knobil,"

Phrase: "E. ,"

Phrase: "and"

Phrase: "Neill,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.580: 2 , pp. 

Phrase: "2 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "pp."
Processing 00000000.tx.581: 478-482, Academic Press, New York 43. 

Phrase: "478-482,"

Phrase: "Academic Press,"

Phrase: "New York 43."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]
Processing 00000000.tx.582: Hutton, J. 

Phrase: "Hutton,"

Phrase: "J."
Processing 00000000.tx.583: C., Penn, E. 

Phrase: "C., Penn,"

Phrase: "E."
Processing 00000000.tx.584: J., and Peshavaria, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Peshavaria,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.585: (1983) Biochem. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.586: J. 

Phrase: "J."
Processing 00000000.tx.587: 210, 297-305[Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "210,"

Phrase: "297-305"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.588: Mains, R. 

Phrase: "Mains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205225:mains [Qualitative Concept]
   966 E C1542147:Main [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.589: E., Cullen, E. 

Phrase: "E.,"

Phrase: "Cullen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1051267:Cullen [Plant]

Phrase: "E."
Processing 00000000.tx.590: I., May, V., and Eipper, B. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "May,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Eipper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.591: A. 

Phrase: "A."
Processing 00000000.tx.592: (1987) Ann. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.593: N.Y.Acad. 

Phrase: "N.Y.Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.594: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.595: 493, 278-291[Abstract] 45. 

Phrase: "493,"

Phrase: "278-291"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 45."
Processing 00000000.tx.596: Orlowski, M., Reznik, S., Ayala, J., and Pierotti, A. 

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "Reznik,"

Phrase: "S."

Phrase: ","

Phrase: "Ayala,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Pierotti,"

Phrase: "A."
Processing 00000000.tx.597: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.598: (1989) Biochem. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.599: J. 

Phrase: "J."
Processing 00000000.tx.600: 261, 951-958[Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "261,"

Phrase: "951-958"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.601: Glucksman, M. 

Phrase: "Glucksman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.602: J., Orlowski, M., and Roberts, J. 

Phrase: "J.,"

Phrase: "Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.603: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.604: (1992) Biophys. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.605: J.(Disc.) 

Phrase: "J.(Disc."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0230716:J disc [Cell Component]
   861   C0180459:DISC [Medical Device]
   861   C1556138:Disc [Body Part, Organ, or Organ Component]
   861   C1705229:Disc [Medical Device]
   861   C2348299:Disc [Spatial Concept]

Phrase: ")"
Processing 00000000.tx.606: 62, 119-122 47. 

Phrase: "62,"

Phrase: "119-122 47."
Processing 00000000.tx.607: Kamtekar, S., and Hecht, M. 

Phrase: "Kamtekar,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hecht,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.608: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.609: (1995) FASEB J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.610: 9, 1013-1022[Abstract/Free FullText] 48. 

Phrase: "9,"

Phrase: "1013-1022"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.611: Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., and Hidaka, H. 

Phrase: "Chijiwa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mishima,"

Phrase: "A.,"

Phrase: "Hagiwara,"

Phrase: "M."

Phrase: ","

Phrase: "Sano,"

Phrase: "M."

Phrase: ","

Phrase: "Hayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Inoue,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Naito,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Toshioka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hidaka,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.612: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.613: Biol. 

Phrase: "Biol."
Processing 00000000.tx.614: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.615: 265, 5267-5272[Abstract/Free FullText] 49. 

Phrase: "265,"

Phrase: "5267-5272"

Phrase: "[Abstract/Free FullText"

Phrase: "] 49."
Processing 00000000.tx.616: Healy, D. 

Phrase: "Healy,"

Phrase: "D."
Processing 00000000.tx.617: P., and Orlowski, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Orlowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.618: (1992) Brain Res. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.619: 571, 121-128[CrossRef][Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "571,"

Phrase: "121-128"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.620: Ganju, R. 

Phrase: "Ganju,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.621: K., Shpekto, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shpekto,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.622: G., Brenner, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brenner,"

Phrase: "D."
Processing 00000000.tx.623: G., and Shipp, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Shipp,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.624: A. 

Phrase: "A."
Processing 00000000.tx.625: (1996) Blood 88, 4159-4165[Abstract/Free FullText] 51. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Blood 88,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "4159-4165"

Phrase: "[Abstract/Free FullText"

Phrase: "] 51."
Processing 00000000.tx.626: Fu, H., Subramanian, R. 

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Subramanian,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.627: R., and Masters, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.628: C. 

Phrase: "C."
Processing 00000000.tx.629: (2000) Annu. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.630: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.631: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.632: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.633: 40, 617-647[CrossRef][Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "617-647"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.634: Muslin, A. 

Phrase: "Muslin,"

Phrase: "A."
Processing 00000000.tx.635: J., Tanner, J. 

Phrase: "J.,"

Phrase: "Tanner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335730:Tanner [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.636: W., Allen, P. 

Phrase: "W., Allen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.637: M., and Shaw, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Shaw,"

Phrase: "A."
Processing 00000000.tx.638: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.639: (1996) Cell 84, 889-897[Medline] [OrderarticleviaInfotrieve] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 84,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "889-897"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

